Emerging Drugs of Abuse Lecture 5 Hour
Upcoming SlideShare
Loading in...5
×
 

Emerging Drugs of Abuse Lecture 5 Hour

on

  • 20,040 views

Emerging drugs of abuse, including synthetic cannabinoids, synthetic cathinones, kratom, hallucinogens, MDMA (Molly), NBOMe, PCP, salvia, DXM, and Lean (Purple Drank). Also covered are emerging ...

Emerging drugs of abuse, including synthetic cannabinoids, synthetic cathinones, kratom, hallucinogens, MDMA (Molly), NBOMe, PCP, salvia, DXM, and Lean (Purple Drank). Also covered are emerging trends of existing drugs of abuse such as opiates, cocaine and alcohol. Last updated on May 12, 2014

Statistics

Views

Total Views
20,040
Views on SlideShare
20,032
Embed Views
8

Actions

Likes
5
Downloads
200
Comments
2

3 Embeds 8

http://www.linkedin.com 4
https://www.linkedin.com 3
http://www.spundge.com 1

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Emerging Drugs of Abuse Lecture 5 Hour Emerging Drugs of Abuse Lecture 5 Hour Presentation Transcript

  • Glenn Duncan LPC, LCADC, CCS, ACS Executive Director Hunterdon Drug Awareness Program, Inc. Presentation Last Updated 12-May-14
  • http://slidesha.re/S6UOXv
  •  Except where control is required by United States obligations under an international treaty, convention, or protocol, in effect on October 27, 1970. The findings required for each of the schedules are as follows:  Schedule I ◦ (A) The drug or other substance has a high potential for abuse. ◦ (B) The drug or other substance has no currently accepted medical use in treatment in the United States. ◦ (C) There is a lack of accepted safety for use of the drug or other substance under medical supervision.
  •  Schedule II ◦ (A) The drug or other substance has a high potential for abuse. ◦ (B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. ◦ (C) Abuse of the drug or other substances may lead to severe psychological or physical dependence.  Schedule III ◦ (A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. ◦ (B) The drug or other substance has a currently accepted medical use in treatment in the United States. ◦ (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
  •  Schedule IV ◦ (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III. ◦ (B) The drug or other substance has a currently accepted medical use in treatment in the United States. ◦ (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III.  Schedule V ◦ (A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV. ◦ (B) The drug or other substance has a currently accepted medical use in treatment in the United States. ◦ (C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV.
  •  Opium natural, semi-synthetic, and synthetic opiates – What Schedule? ◦ Depends: Heroin, Desomorphine (infamous due to “Krokodil”) - (Schedule I), Dilaudid, Fentanyl, Oxycontin, Percoset, Roxycontin, and Methadone - (Schedule II), Codeine, Vicodin, Buprenorphine, and Low Dosages of Morphine - (Schedule III), and lowest dosages of codeine, opium and other low dosages of opiate agonists - (Schedule V)  Cocaine – What Schedule? Amphetamines and Methamphetamines – Schedule? ◦ Cocaine - (Schedule II) ◦ Amphetamines and Methamphetamines (Schedule II)  Marijuana – What Schedule? ◦ Marihuana (as the government likes to call it) - (Schedule I) The government does not recognize medical marijuana.  Hallucinogens – What Schedule? ◦ Depends: Most hallucinogens (LSD [Lysergic Acid Diethylamide], Psilocybin, Peyote, Bromo DragonFly, etc.) – (Schedule I), Lysergic Acid (precursor to LSD but technically not an hallucinogen) and Dronabinol (Marinol – Medical Marijuana) – (Schedule III).
  •  Alcohol - In the 1700’s and 1800’s, some states initiated efforts to control alcohol use, specifically to restrict use by Native Americans.  Alcohol prohibition (1920’s) was in part a response to the drinking practices of poor European immigrants, who became the new lower class.  Prohibition represented a conflict between urban and rural values emerging in the United States. Given the mass influx of immigrants to the urban dwellings of the United States, many individuals within the prohibition movement associated the crime and morally corrupt behavior of the cities of America with their large immigrant populations.  In a backlash to the new emerging realities of the American demographic, many prohibitionists subscribed to the doctrine of “nativism” in which they endorsed the notion that America was made great as a result of its white Anglo-Saxon ancestry.  This fostered xenophobic sentiments towards urban immigrant communities who typically argued in favor of abolishing prohibition. Additionally, these nativist sentiments were a part of a larger process of Americanization taking place during the same time period.
  •  Opium was first restricted in San Francisco California in 1875 when it became associated with Chinese immigrant workers and opium dens.  This was followed by other laws throughout the country, and federal laws which barred Chinese people from trafficking in opium.  Though the laws affected the use and distribution of opium by Chinese immigrants, no action was taken against the producers of such products as laudanum (and other “elixirs”), an extract of opium and alcohol, commonly taken as a panacea by white Americans.  The Harrison Tax Act in 1914 proceeded to first tax and “track” the use of both opiates and cocaine.  Due to this Act, it became legal precedent that any prescription for a narcotic given by a physician or pharmacist – even in the course of medical treatment for addiction - constituted conspiracy to violate the Harrison Act, and thus the temporary criminalization of any opiates, even for medical reasons.
  •  Due to this Act, it became legal precedent that any prescription for a narcotic given by a physician or pharmacist – even in the course of medical treatment for addiction - constituted conspiracy to violate the Harrison Act, and thus the temporary criminalization of any opiates, even for medical reasons.  Heroin was first synthesized in London 1873. It was independently synthesized 23 years later by a Bayer. From 1898 – 1910 Bayer marketed Heroin as a non-addictive morphine substitute and cough suppressant.  Bayer marketed the drug as a cure for morphine addiction before it was discovered that it rapidly metabolizes into morphine.  As such, diacetylmorphine (heroin) is essentially a quicker acting form of morphine. The company was embarrassed by the new finding, which became a historic blunder for Bayer.
  •  Marijuana was legal until the 1930s when it became associated with Mexican immigrants.  Before the 1930’s state by state passed marijuana legislation, which was due to the tensions developed by the influx of Mexican’s into these states following, and during, the revolution in Mexico in 1910. Many immigrant Mexican’s brought with them marijuana.  When Montana outlawed marijuana in 1927, the Butte Montana Standard reported a legislator’s comment: “When some beet field peon takes a few traces of this stuff… he thinks he has just been elected president of Mexico, so he starts out to execute all his political enemies.” In Texas, a senator said on the floor of the Senate: “All Mexicans are crazy, and this stuff [marijuana] is what makes them crazy.”  Eastern states are also said to be influence by Jazz musicians use, thus associating African Americans to a lesser extent with prohibition of pot.
  •  Cocaine became illegal after it became associated with African Americans following Reconstruction.  The dangers of cocaine use became part of a moral panic that was tied to the dominant racial and social anxieties of the day.  In 1903, the American Journal of Pharmacy stressed that most cocaine abusers were "bohemians, gamblers, high- and low-class prostitutes, night porters, bell boys, burglars, racketeers, pimps, and casual laborers."  In 1914, Dr. Christopher Koch of Pennsylvania's State Pharmacy Board made the racial innuendo explicit, testifying that, “Most of the attacks upon the white women of the South are the direct result of a cocaine-crazed Negro brain."  Mass media manufactured an epidemic of cocaine use among African Americans in the Southern United States to play upon racial prejudices of the era, though there is little evidence that any such an epidemic actually took place.  At that time, the 1914 Harrison Tax Act was enacted on cocaine and opium.
  •  LSD, legal in the 1950s, became illegal in 1968 when it became associated with the counterculture.  Several figures, including Aldous Huxley, Timothy Leary, and Al Hubbard, began to advocate the consumption of LSD. LSD became central to the counterculture of the 1960s.  On October 24, 1968, possession of LSD was made illegal in the United States.  The last FDA approved study of LSD in patients, ended in 1980, while a study in healthy volunteers was made in the late 1980s.  Today, medical research around LSD is resuming around the world.
  • Schematic highlighting the major families and subfamilies of research chemicals, and some of their most prominent members.
  • (a.k.a. “Bath Salts”) Glenn Duncan LPC, LCADC, CCS, ACS Presentation Last Updated 12-May-14
  •  Synthetic cathinones are related to the parent compound cathinone.  Since the mid-2000s, unregulated ring-substituted cathinone derivatives have appeared in the European and American recreational drugs market.  The most commonly available synthetic cathinones sold on the recreational market in the period up to 2011 appear to be 3, 4- Methylenedioxypyrovalerone (MDPV), mephedrone, and methylone.  These products are usually encountered as highly pure white or brown powders. Cathinone derivatives are claimed to have effects similar to those of cocaine, amphetamine or MDMA (ecstasy), but little is known of their detailed pharmacology.
  •  The term ‘bath salts’ refer to commercially available products that have as part of their composition a legal stimulant (synthetic cathinone) called 3, 4- Methylenedioxypyrovalerone, or MDPV.  Currently illegal in New Jersey and illegal nationally (3 synthetic cathinones [MDPV, Mephedrone and Methylone] were placed on temporary emergency ban October 21, 2011 by the DEA). They are sold mostly on the internet, but can also be found in select shops locally. They're known by a variety of names, including “Red Dove,” “Blue Silk,” “Zoom,” “Bloom,” “Cloud Nine,” “Ocean Snow,” “Lunar Wave,” “Vanilla Sky,” “Ivory Wave,” “White Lightning,” “Scarface” “Purple Wave,” “Blizzard,” “Star Dust,” “Lovey, Dovey,” “Snow Leopard,” “Aura,” and “Hurricane Charlie.” While they have become popular under the guise of selling as ‘bath salts’, they are sometimes sold as other products such as insect repellant, or plant food with names like “Bonsai Grow” among others.  Much like the marketing of Synthetic Cannabinoids (Spice/K2) as incense, MDPV has been market as “bath salts” and just like Spice/K2 MDPV is specifically labeled “not for human consumption.”
  •  There are other drugs with a similar chemical structure to MDPV.  These include α-pyrrolidinopropiophenone (α-PPP). Little is known about this compound, but it has been detected by laboratories in Germany as an ingredient in "ecstasy" tablets seized by law enforcement authorities.  4'-methyl-α-pyrrolidinopropiophenone (MPPP) is a stimulant drug. It is very structurally similar to α-PPP. MPPP was sold in Germany as a designer drug in the late 1990s and early 2000s,although it has never achieved the same international popularity as its better-known relations α-PPP and MDPV.  3',4'-methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a stimulant designer drug. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation ecstasy (MDMA) pills. It shares a similar chemical structure with α-PPP and MDPV.
  •  Because of the emerging nature of these drugs, most specifically MDPV to the US marketplace, there seems to be confusion regarding MDPV and other drugs such as Mephedrone (4-MMC) being used in bath salts.  Mephedrone, also known as 4-methylmethcathinone (4-MMC), or 4- methylephedrone, is a synthetic stimulant drug of the amphetamine and cathinone classes. Slang names include “meph,” “drone,” and “MCAT.”  It is reportedly manufactured in China and is chemically similar to the cathinone compounds found in the khat plant of eastern Africa. It comes in the form of tablets or a powder, which users can swallow, snort or inject, producing similar effects to MDMA, amphetamines and cocaine.  In July, 2010, the DEA listed Mephedrone a “drug and chemical of concern.”
  •  Cosmic Blast, marketed as a jewelry cleaner, is a stimulant/hallucinogen that is being marketed in the same way bath salts were. Drug sellers don’t seem to care about US drug law in that samples of Cosmic Blast that have been tested in toxicology laboratories have been known to contain. MDPV.  It can also contain Naphyrone (which became popular in the UK after their ban of Mephedrone recently).  Naphyrone also known as O-2482 and naphthylpyrovalerone, is a drug derived from pyrovalerone that acts as a triple reuptake inhibitor, producing stimulant effects and has been reported as a novel designer drug. No safety or toxicity data is available on the drug).  Anecdotal reports of Naphyrone are it can stay in your body for long periods and since it is a reuptake inhibitor of Serotonin, which is implicated in body heat regulation, body temperatures can soar upwards of 107-108 degrees.
  •  Pentedrone, also known as 2-(methylamino)-1-phenylpentan-1-one or α-methylamino- valerophenone, is a designer drug with presumably stimulant effects, which has been found since 2010 as an ingredient in a number of "bath salt" mixes sold as legal highs.  Alpha-PVP - α-Pyrrolidinopentiophenone (alpha-Pyrrolidinovalerophenone,α-PVP, O-2387,alpha-PVP) is a stimulant compound developed in the 1960s and related to pyrovalerone. The mechanism of action is unknown for α-pyrrolidinopentiophenone. α-PVP is believed to act similarly to the designer drug MDPV, which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), although no substantial research on this compound has been conducted.  3,4-DMMC - 3,4-Dimethylmethcathinone is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.
  •  MDPV was developed in the 1960s, and has been used for the treatment of chronic fatigue, but caused problems of abuse and dependence.  1969: Boehringer Ingelheim files a patent application for MDPV.  2005: MDPV appears as a recreational drug; first mention on Drugs-Forum.  2007: First seizure of MDPV as a recreational drug, by customs officials in the German state of Saxony. The drug had been shipped from China.  2008: First seizure of MDPV in the United States.  2009: MDPV made illegal in Denmark.  2010: MDPV made a controlled drug in the UK, Sweden, Germany, Australia and Finland. First reports of the widespread retail marketing of 'bath salts' containing MDPV in the US. The US considers both Mephedrone (July, 2010) and MDPV (December, 2010) "a drug and chemical of concern".  2011: MDPV sale and possession are banned in 31 US States, with legislation being introduced in many other states.
  •  MDPV is a powerful stimulant that functions as a dopamine-norepinephrine reuptake inhibitor (NDRI). It has stimulatory effects on the central nervous system and cardiovascular system. 1. physical: rapid heartbeat, increase in blood pressure, vasoconstriction, sweating. 2. mental: euphoria, increases in alertness & awareness, increased wakefulness and arousal, anxiety, agitation, perception of a diminished requirement for food and sleep.  MDPV reportedly has four times the potency of Ritalin and Concerta.  MDPV is sometimes labeled online as legal cocaine or legal amphetamines.  The effects have a duration of roughly 3 to 4 hours, with after effects such as tachycardia, hypertension, and mild stimulation lasting from 6 to 8 hours. High doses have been observed to cause intense, prolonged panic attacks in stimulant-intolerant users, and there are anecdotal reports of psychosis from sleep withdrawal and addiction at higher doses or more frequent dosing intervals.
  •  Aggression  Agitation  Breathing difficulty  Bruxism (grinding teeth)  Confusion  Dizziness  Extreme anxiety sometimes progressing to violent behavior  Fits and delusions  Hallucinations  Headache  Hypertension (high blood pressure)  Increased alertness/awareness  Increased body temperature, chills, sweating  Insomnia  Kidney pain  Lack of appetite  Liver failure  Loss of bowel control  Muscle spasms  Muscle tenseness  Vasoconstriction (narrowing of the blood vessels)  Nausea, stomach cramps, and digestive problems  Nosebleeds  Psychotic delusions  Pupil dilation  Renal failure  Rhabdomyolysis (release of muscle fiber contents [myoglobin] that could lead to kidney problems)  Severe paranoia  Suicidal thoughts  Tachycardia (rapid heartbeat)  Tinnitus
  •  Yes. Until a drug is tested, it cannot be considered safe. MDPV and its ‘chemical cousins’ have not been tested by the FDA and thus little is known as to the harm potential. Some anecdotal stories involving ‘bath salt’ usage and their potential for harm come in news stories from across the nation, local emergency room reports and data collected from the American Association of Poison Control Center.  In New Jersey, on March 16, 2011 a young man reportedly addicted to Bath Salts and also suffering from Bipolar Disorder, killed his girlfriend at his home. This tragic death of a Rutgers University student prompted three NJ legislatures to introduce a bill to ban the active ingredients in these “bath salts”.  There have been reports that clients are reporting chest pains, increased blood pressure, increased heart rate, agitation, hallucinations, extreme paranoia, and delusions and suicidal thoughts. One online report from Louisiana has attempted to correlate 3 deaths with prior usage of MDPV. Many of the anecdotal reports are saying these compounds found in “bath salts” can quickly cause people to crave re-use of the substance, and are strongly addicting.
  •  New research (December 14, 2011) by scientists at the National Institute on Drug Abuse (NIDA) indicates that the active compounds in "bath salts" (mephedrone and methylone) bind to monoamine transporters on the surface of some neurons.  This in turn leads to an increase in the brain chemical serotonin, and to a lesser extent, dopamine, suggesting a mechanism that could underlie the addictive potential of these compounds.  “Our data demonstrate that designer methcathinone analogs are substrates for monoamine transporters, with a profile of transmitter-releasing activity comparable to 3,4-methylenedioxymethamphetamine (MDMA, or 'ecstasy').”  “Given the widespread use of mephedrone and methylone, determining the consequences of repeated drug exposure warrants further study.”
  •  Analysis of the ratio of the AUC for dopamine (DA) and serotonin (5-HT) indicated that mephedrone was preferentially a serotonin releaser, with a ratio of 1.22:1 (serotonin vs. dopamine).  Additionally, half-lives for the decrease in DA and 5-HT were calculated for each drug. Mephedrone had decay rates of 24.5 minutes and 25.5 minutes, respectively.  MDMA had decay values of 302.5 minutes and 47.9 minutes, respectively, while amphetamine values were 51 minutes and 84.1 minutes, respectively.  Taken together, these findings show that mephedrone induces a massive increase in both DA and 5-HT, combined with rapid clearance. The rapid rise and subsequent fall of DA levels could explain some of the addictive properties that mephedrone displays in some users.
  •  On October 21, 2011, the United States Drug Enforcement Administration (DEA) exercised its emergency scheduling authority to control three synthetic stimulants (Mephedrone , 3,4 methylenedioxypyrovalerone (MDPV) and Methylone) used to make products marketed as “bath salts” and “plant food”.  Except as authorized by law, this action makes possessing and selling these chemicals, or the products that contain them, illegal in the United States.  These chemicals will be controlled for at least 12 months, with the possibility of a six month extension, while the DEA and the United States Department of Health and Human Services (DHHS) further study whether these chemicals should be permanently controlled.  In this press release, DEA Administrator Michele M. Leonhart stated “these chemicals pose a direct and significant threat, regardless of how they are marketed, and we will aggressively pursue those who attempt their manufacture and sale.”  The “Food and Drug Administration Safety and Innovation Act” (now a law as of July 9, 2012) extends temporary bans from 18 months in total, to 36 months in total.
  •  The “Food and Drug Administration Safety and Innovation Act” (2012) is proposing to extend temporary bans from 18 months in total, to 36 months in total.  The Senate on May 24, 2012 passed the “Food and Drug Administration Safety and Innovation Act” which has in it, a synthetic drug section (Title XI, Subtitle D – Section 1152).  This act, passed by both houses of Congress, bans 31 different synthetic drugs. The first version of this bill passed by the house had 17 synthetic cathinones (and cathinone substitutes) listed. However, this section was reduced significantly when pass through the Senate, and the final bill appears to have gone from 17 to 2: MDPV and Mephedrone.  The FDA Safety and Innovation Act was signed into law by President Obama on July 9, 2012.
  •  304 in 2010  6,136 in 2011  2,691 in 2012  995 in 2013  For 2014 the data is as follows – 236 calls (January 1 – April 30, 2014) ◦ January 2014 46 calls. ◦ February 2014 58 calls. ◦ March 2014 71 calls. ◦ April 2014 61 calls.
  • DMEC Methedrone Ethedrone 3-MOMC 2-FMC 2-FEC 3-FMC 3-FEC 3-CMC 3-BMC Flephedrone 4-FEC Brephedrone FMMC 2,5-DMOMC bk-MDA 2,3-MDMC Methylone Ethylone BMDP bk-IMP 4-Fluorobuphedrone 4-Bromobuphedrone 4-MeMABP 4-Me-NEB 4-Methoxybuphedrone Butylone Eutylone BMDB bk-DMBDB 5-Methylmethylone 5-Methylethylone 2-Methylbutylone 5-Methylbutylone Pentylone MMP MEP bk-Methiopropamine α-Phthalimidopropiophenone α-PPP α-PBP 3-MPBP EPBP MOPBP O-2384 α-PVP (O-2387) Chuck Schumer on July 9, 2012 stated the following on his website: “President’s Signature Hammers Final Nail in Coffin for Legal Bath Salts” …. Oh really? I guess these don’t exist: New Title! Schumer’s Legislation puts 2 nails in a coffin in need of at least 81 more nails!
  •  As of July 9, 2012, here are the known states to have banned Bath Salts; banning either Mephedrone, MDPV, Methylone and/or other cathinones (this list has literally grown rapidly, so please understand if a state has not been listed here that recently passed a ban):  Alabama (MDPV, Mephedrone)  Arkansas (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  Arizona  Connecticut  Delaware (MDPV, Mephedrone, Methylone)  Florida (MDPV, Mephedrone, Methylone, 3-FMC, BK-PMMA)  Georgia (MDPV, Mephedrone, Methylone, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  Hawaii (MDPV, Mephedrone)  Idaho (MDPV, Mephedrone)  Indiana  Illinois (MDPV)  Iowa  Kansas (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone], Butylone)  Kentucky (MDPV, Mephedrone, Methylone)  Louisiana (MDPV, Mephedrone, Methylone, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  Maine (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone], Butylone)  Michigan  Minnesota  Mississippi (MDPV, Mephedrone)  Missouri (MDPV, Mephedrone, MPBP [4'-Methyl-α-pyrrolidinobutiophenone])
  •  As of July 9, 2012, here are the known states to have banned Bath Salts; banning either Mephedrone, MDPV, Methylone and/or other cathinones (this list has literally grown rapidly, so please understand if a state has not been listed here that recently passed a ban):  New Jersey (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  New Mexico (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  New York (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  North Carolina (MDPV, Mephedrone)  North Dakota (Mephedrone only)  Ohio (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  Oklahoma (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  Oregon (MDPV, Mephedrone, Methylone, 4-FMC [Flephedrone], BK-PMMA [Methedrone], Butylone)  Pennsylvania (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  South Carolina (MDPV, Mephedrone, Methylone)  South Dakota  Tennessee (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  Texas (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])  Utah (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone], Butylone)  Virginia (MDPV, Mephedrone)  Washington (MDPV, Mephedrone, and synthetic cannabinoids, analogues) – Effective November 3, 2011  West Virginia (MDPV, Mephedrone)  Wisconsin (MDPV, Mephedrone)  Wyoming (MDPV, Mephedrone, Methylone, 3-FMC, 4-FMC [Flephedrone], BK-PMMA [Methedrone])
  •  On April 29th , 2011 MDPV, Mephedrone, Methylone and 3 other synthetic cathinones were banned in New Jersey.  This ban in New Jersey was caused by very swift action by the legislature and Division of Consumer Affairs. On March 16, 2011, it was announced Assembly Deputy Speaker John McKeon (D-Essex), Assemblywoman Linda Stender (D-Union), and state Senator John Girgenti (D-Passaic) sponsored the legislation introduced into the Assembly and Senate, that led to the ban on MDPV, Mephedrone, Methylone and the 3 other synthetic stimulants 6 weeks later. The 6 banned substances are: 1. 3,4 – Methylenedioxypyrovalerone (MDPV) 2. 4 – Methylmethcathinone (Mephedrone, 4-MMC) 3. 3,4 – Methylenedioxymethcathinone (Methylone, MDMC) 4. 4 – Methoxymethcathinone (Methedrone, bk-PMMA, PMMC) 5. 4 – Fluoromethcathinone (Flephedrone, 4-FMC) 6. 3 – Fluoromethcathinone (3-FMC)
  •  Because of the state ban on April 29, 2011, this currently means in New Jersey MDPV and many of its derivatives and analogues (or chemical cousins to use the term from a previous slide), are no longer accessible.  In other states where bans have not been in place, the product is being sold as ‘bath salts’ and labeled “Not For Human Consumption”, thus there are no age restrictions on the purchase of these products (as you have with other legal, intoxicating substances such as alcohol).  Governor Christie made this temporary action permanent by signing Pamela's Law, banning the sale and possession of the 6 aforementioned synthetic cathinones. Pamela's Law was named after Pamela Schmidt, a 22-year-old Rutgers student who is believed to have been murdered by her boyfriend, Bill Parisio, who is said to have been under the influence of “bath salts” at the time of the March incident.  However, toxicology results of Mr. Parisio taken shortly after the murder showed there were none of these synthetic cathinones in his system.
  •  Because national public health officials have MDPV, Mephedrone and Methylone on their radar, it has been placed on a 12 month temporary national ban that started on October 21, 2011.  In December, 2010, the DEA made a brief statement: “Currently, MDPV is not a scheduled drug under the Controlled Substances Act (CSA). However, if intended for human consumption, MDPV can be considered an analogue of a schedule I drug under the CSA (Title 21 United States Code 813). Therefore, law enforcement cases involving MDPV can be prosecuted under the Federal Analogue Act of the CSA.” However, all “bath salts” clearly state “Not for Human Consumption”.  What this means is that (if in your state) MDPV is not a scheduled drug currently, if the intention is to use it for human consumption, its structural similarity to illegal drugs of abuse means that it could be considered by law enforcement officials as a controllable substance analogue (under the Federal Analogue Act).
  •  Just because a federal ban is enacted on a drug, it does not mean local authorities will take action on this drug.  States still need to enact legislation to ban the substances in order for state (then local) authorities to take action.  Federal bans will go after larger distributors, but it will be locally determined as to whether users and smaller, local distributors (such as non-chain convenience stores and gas stations) will be sought after without a state ban.
  •  This is from a recent study out of the United Kingdom.  Mephedrone (4-methylmethcathinone) and related cathinones were controlled in the United Kingdom on 16 April 2010.  An analysis of presentations to the emergency department of patients with acute toxicity related to the use of mephedrone demonstrated that there was a peak in presentations prior to and a significant fall in presentations following the control of mephedrone.  This suggests that the control of mephedrone in the United Kingdom may have been effective in reducing the acute harm associated with the drug.
  •  Redwood Toxicology Laboratory shows currently they have detection for MDPV and Mephedrone. They do not have detection for α-PPP, MPPP or MDPPP in urine drug screens. The cost for the 2 panel is $40 ($30 if you do enough volume and have your entire drug screen business with Redwood Lab.), and $55 ($40) for the 14 panel test. There is reportedly a 48-72 hour detection window, depending on dosing.  Redwood has a 2 panel drug test (MDPV, Mephedrone) and a 14 panel drug test which tests for the following drugs: 1. BZP (Benzylpiperazine) 2. Butylone (β-keto-N-methylbenzodioxolylpropylamine, bk-MBDB) 3. Cathinone (Khat or Benzoylethanamine) 4. Ethylone (3,4-methylenedioxy-N-ethylcathinone, MDEC, bk-MDEA) 5. MBDB (Methylbenzodioxolylbutanamine, Methyl-J, “Eden”) 6. mCPP (meta-Chlorophenylpiperazine) 7. MDA (3,4-Methylenedioxyamphetamine, tenamfetamine) 8. MDEA (3,4-Methylenedioxy-N-ethylamphetamine, MDEA, MDE, “Eve”) 9. MDPV (Methylenedioxypyrovalerone, Cloud 9, Ivory Wave, White Lightning) 10. MDMA (3,4-Methylenedioxymethamphetamine, ecstasy, “E”, “X”) 11. Mephedrone (4-methylmethcathinone [4-MMC], 4-methylephedrone, “Meph”, “MCat”) 12. Methcathinone (α-methylamino-propiophenone, may be confused with mephedrone) 13. Methylone (3,4-methylenedioxy-N-methylcathinone, bk-MDMA, MDMC, “M1”) 14. TFMPP (3-Trifluoromethylphenylpiperazine, “Legal X”)
  • This bad … Man arrested after being found standing over goat, wearing women's underwear http://bit.ly/mr2xny  May 3, 2011. CHARLESTON, W.Va. – An Alum Creek man has been arrested after neighbors allegedly found him standing over the dead body of a boy’s stolen pet pygmy goat while wearing women's underwear.  The goat was named Bailey, was on a leash attached to a tree in the front yard. The small white- and-gray goat wore a pink collar.  The 19 year old man told deputies he had been high on bath salts for the last three days, said a detective with the sheriff's office.   Two of the three people who were with the boy who’s pet pygmy goat was abducted, went to the suspect's home to look for the goat and found the front door open. They went inside the house, and one went into the middle bedroom where she found the suspect in a bra and woman's panties standing three feet from the goat's body. The suspect then ran out of the house wearing only a muscle shirt and thong underwear. Bath salts are ‘cross dress, kill a little boy’s pet pygmy goat, then run in public’ bad.
  • Nom Nom Nom!
  • The Anecdotal “Evidence” …  May 3, 2011. CHARLESTON, W.Va. – An Alum Creek man has been arrested after neighbors allegedly found him standing over the dead body of a boy’s stolen pet pygmy goat while wearing women's underwear. This was our trendsetter http://bit.ly/mr2xny.  May and June, 2012 – A veritable outbreak of Zombie type behaviors with people the media reported that were supposedly on bath salts (mostly in Florida … fill in your own thoughts on this): 1. Florida Man (Rudy Eugene) Eats 75% of Another Man’s Face 2. NJ Man Flings His Own Intestines at Police Who Try to Arrest Him 3. Man on Bath Salts Bites a Chunk of Person’s Face in Domestic Dispute 4. Man on Bath Salts Threatens to Eat Police Who Try to Arrest Him  Of course the most infamous of these is link #1, where the mother actually talked to the press to announce that her now deceased son (they had to kill him as when the police tried to stop him from eating the other man he merely growled at them) “was no zombie” and his former girlfriend stated he was either drugged or possessed. Rudy Eugene was on marijuana only, not bath salts. He was also found to have no human flesh in his stomach. However, the lab only tested for 6 chemicals, and as we have seen there are more than 6 chemicals being used/labeled as “bath salts”.  It doesn’t help that Center for Disease Control has a permanent internet website dedicated to how to best handle a Zombie Apocalypse.
  • More recent rash of bizarre and deadly bath salts incidents  June 18, 2012. Houston, Texas - A man was found in the middle of a busy street shouting incoherently at oncoming traffic that swerved to miss him. Police finally got him out of the traffic when he “displayed signs of excited delirium” before he stopped breathing. He was pronounced dead at the hospital and had bath salts on him.  June 14, 2012. Miami, Florida - A naked woman punched and choked her 3 year old son before the son was . She then grabbed her dog and did the same before the police came and tasered. She died from cardiac arrest as a result of the tasering (and likely drugs).
  •  June 15, 2012. Robinson, Illinois - A naked man grabs onto random car hood while naked and surfs car hood fo . The driver calls 911 and drives 4 miles to meet police who then arrested the man, who had vials purportedly containing bath salts on him. The driver was given a special commendation for delivering the perp in under 30 minutes.  October 3, 2012. Tempe Arizona – A man was arrested after being found naked while making out with the steering wheel of a U-Ha . Investigators say when officers arrived on the scene, John Hurtado, aged 20, was still inside the U-Haul truck, kissing the steering wheel. Hurtado was reportedly rambling and acting irrationally. He was apprehended and placed inside a squad car, where he began kissing the cage. The U-Haul Truck has since filed a restraining order and entered into counseling as it witnessed Hurtago cheating on it with the police cruiser.
  • The Facts …  MDPV, Mephedrone, and other synthetic cathinones can cause serious psychiatric symptoms in people who have never exhibited such symptoms prior to usage.  This can happen for some, while others will never experience these symptoms under the influence of these chemicals. However, the prevalence of people having abreactions is evident in Poison Control Center data, and in these types of anecdotal stories linked in the previous slide.  For those who have pre-existing psychiatric problems, ingesting these substances can further fracture and intensify these pre-existing psychiatric symptoms, which can be expressed in violent ways by some.  There is no evidence of continued "zombiefication" of bath salt users after the drugs have left their system. Thus any zombie like tendencies (i.e., aggression leading to the severe mutilation of oneself or others) that could possibly exist, would only do so while under the influence, and wouldn't persist after the effects of the drug have left a person's system.  Sorry, no Hollywood zombie apocalypse is evident with "bath salts" ingestion, only tragic consequences.
  • Glenn Duncan LPC, LCADC, CCS, ACS Presentation Last Updated 12-May-14 Emerging Drugs of Abuse Synthetic Cannabinoids – Spice/K2
  •  The terms Spice and K2 refer to commercially available products that have been sprayed with research chemicals called synthetic cannabinoids but do not contain any cannabis (marijuana) components.  Currently illegal in New Jersey (and there is an emergency national ban on 5 synthetic cannabinoids), they are sold in local markets throughout the U.S. including gas stations, liquor stores, convenient stores, smoke shops, or on the Internet under the brand names "K2," "Spice," “Chronic Spice," "Spice Gold," "Spice Silver," "Stinger," "Yucatan Fire," "Skunk," “Pulse," "Black Mamba," “Mystery," "Red X Dawn," "Zohai," "Mr. Nice Guy," “Spicylicious," “K3," “K3 Legal," “Earthquake," or "Genie." This listing of names only covers some of the brand names, where more brand names crop up very often.
  •  Synthetic cannabinoids are a structurally diverse class of mostly synthetic substances that bind to cannabinoid receptors in our body, and when ingested create a similar type of high that naturally occurring cannabinoids (marijuana) produce.  More than 250 different synthetic cannabinoids have been created (mostly created in laboratories for research purposes).  The psychoactive compounds found in Generation 1 of Spice and K2 include the synthetic cannabinoids JWH-018, JWH-073, JWH-250, CP 47,497 and/or CP 47,497 C8. Other synthetic cannabinoids include JWH-019, JWH-081, JWH-200, HU-210, CP 55,940 (we have a more comprehensive listing later in this presentation).
  •  True or False – John Crapper invented the modern toilet.  False – He was a plumber who did a lot to improve the modern toilet (e.g., he invented the ball float valve). His name was Thomas Crapper (not John). Historically, the term crap predates Thomas in its use to denote excrement. Sir John Harrington invented the modern toilet for the Queen of England circa 1591.  True or False – Otto Titzling invented the modern bra. Also credited around the same time are Hans Delving and Philippe de Brassiere.  False - Otto Titzling never existed in the first place. Nor did Hans Delving, nor Philippe de Brassiere. They are all fictitious characters invented by Canadian author Wallace Reyburn for his wholly satirical "history" of the brassiere published in 1972, Bust-Up: The Uplifting Tale of Otto Titzling and the Development of the Bra. Reyburn based the names on crude, if memorable, puns — Otto Titzling ("tit-sling"), Hans Delving ("hands delving"), Philippe de Brassiere ("fill up the brassiere"). According to Life magazine, in 1889 Herminie Cadolle of France invented the first modern bra.
  •  The cannabinoid-like chemicals were developed in research laboratories, for example, to study neuronal receptors found in the body and brain.  One of these synthetic cannabinoids, JWH-018, was first made in 1995 for experimental purposes in the lab of Clemson University researcher John W. Huffman, PhD.  It is believed that the manufacturers of "Spice" read the research (circa 2004) and copied it in order to reproduce Dr. Huffman's chemicals to produce the synthetic cannabinoid and market it for commercial distribution.
  •  The cannabinoid-like chemicals were developed in research laboratories to study neuronal receptors found in the body and brain, or for other research purposes.  The five nationally banned synthetic cannabinoids are JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol (CP 47,497 C8, a homologue of CP 47,497).  CP 47,497 was developed in 1980 by Pfizer and has analgesic properties. Cannabicyclohexanol (CP 47,497 C8) was developed by Pfizer in 1979.
  •  HU-210 and HU-211 were first synthesized in 1988 at Hebrew University in Israel, and they have anti-inflammatory and anesthetic properties, respectively.  While HU-210 is anywhere from 100 to 800 times more potent than natural THC, and is a potent analgesic, HU-211 does not act on the cannabinoid receptor and does not produce cannabis type effects when ingested, though it is commonly listed as a synthetic cannabinoid.  HU-210 is currently classified nationally as a schedule 1 controlled substance, though state by state it may be legal.
  •  The brand "Spice" was released in 2004, and in 2006 the brand gained popularity, particularly throughout Europe. The company that started Spice went from assets of 65,000 Euros in 2006 to 899,000 Euros in 2007.  Spice was the dominant brand until 2008 when competing brands hit the market (such as K2).  In 2009 Spice products were identified in 21 countries. Spice, K2 and other products peaked in popularity in 2008 in Europe, with many European countries banning it at that time.  In 2009, Spice, K2 and others gained their popularity in Canada and the United States.
  •  Since the psychoactive ingredients are similar to those of naturally grown marijuana, the effects are similar.  Synthetic cannabinoids are listed as the same class of drug as marijuana; a hallucinogen.  The effects of smoking JWH-018 has a variable duration. Some sites we have viewed report the high lasts probably an average of 10-30 minutes, while anecdotal reports from users of K2 report effects lasting for 1-2 hours.  Synthetic cannabinoids have tested at least 5 - 45 times more potent than some of the strongest marijuana (with HU-210 again being 100-800 times more potent than naturally occurring THC).  A neurophysiology theory on the better potency of synthetic cannabinoids over natural marijuana is that the synthetic cannabinoids bind better and longer to the CB1 and CB2 receptors than does natural THC.
  •  JWH-018  JWH-019  JWH-073  JWH-081  JWH-122  JWH-133 (non-psychoactive)  JWH-200  JWH-201  JWH-203  JWH-210  JWH-250  JWH-251  JWH-398  RCS-4  RCS-8  WIN 48,098  WIN 55,212-2  WIN 55,212-3  MAM-2201  UR-144  XLR-11  AM-630  AM-679  AM-694  AM-1221  AM-1241  AM-2201  CB-25  CB-52  CP 47,497  CP 47,497 C8  CP 55,940  HU-210  HU-211  HU-308  HU-331  JWH-007  JWH-015
  •  AM prefaced compounds are fluorinated and named for Northeastern University professor Alexandros Makriyannis.  CP compounds were developed in the late 1970’s, early 1980’s by Pfizer.  HU compounds are named after Hebrew University where these compounds were first created and investigated.  As stated earlier, JWH products were named after John W. Huffman from Clemson University.  RCS compounds appear to have their origins of development in a single lab in mainland China.  WIN compounds were developed by Sterling Winthrop.
  • The AM class:  This class contains hyperpotent cannabinoids based on CB1 binding affinity, with a fluorine on the end of the pentyl chain in an apparent attempt to increase duration of effect. AM-2201 has been frequently reported. The RCS class:  With a chemical structure reminiscent of JWH-081, this synthetic cannabinoid has similar potency and effects to JWH-250, all allegedly without legal issues or the known JWH ‘anxiety issues’. RCS-4 has been frequently reported. And Yes, The JWH class:  In June and July of 2011, there have been anecdotal internet reports that JWH-122 has been identified in Generation 2 of synthetic cannabinoids.
  •  Recently one supplier of herbal products is even giving out a product analysis report allegedly showing that their product contains none of the banned substances.  Theorycrafting about what is in the next general of K2/Spice leans towards the RCS class. Click this link to see the product analysis report the herbal substance provider gave to their local outlets.  There were 7 JWH class drugs represented in the analysis (015, 018, 019, 073, 081, 200, and 250). There were also 3 CP class drugs represented (47,497, 47,497 C8, 55,940); 4 HU class drugs represented (210, 211, 308, 331); 2 WIN (48,098, 55,212-2); and 1 AM class represented in this analysis report (694).  Conspicuously absent from this report were the RCS and CB classes. However, there is much more internet chatter regarding RCS class of synthetic cannabinoids than there is about the CB class (e.g., there is no CB class Wikipedia page, but there are rudimentary RCS class Wikipedia pages).
  •  Just to make the other two slides outdated, the front line people (chemists in labs trying to stay ahead of the curve and keep their drug testing relevant) have informed that they are seeing new trends.  Yes they still see AM-2201, JWH and RCS-4 in products. Sherri Kacinko, a toxicologist for NMS Labs, states the following: “AM-2201, JWH and RCS-4 are "old news" around here. we are seeing a decrease in positivity in our biological specimens (though plenty are still positive) and a bigger decrease in the solid dosage products. The new biggies seem to be UR-144 and XLR-11.”  Another person also reflected this sentiment and added that MAM-2201 is being found in recent (June, 2012) samples. So what are these new chemicals?  According to Ms. Kacinko: “MAM-2201 is AM-2201 with a methyl group on the ring. XLR-11 is the UR-144 (click this link to see info on UR-144) with a Fluorine at the terminus of the side change (like AM-2201 is JWH-018 with a fluorine).”
  •  Yes. Until a drug is tested, it cannot be considered safe. Not only have synthetic cannabinoids not been tested, nearly all were created for experimental use in animals and cell cultures, not tested for use in humans.  JWH-018 inventor John W. Huffman, PhD, puts it bluntly: "It is like Russian roulette to use these drugs. We don't know a darn thing about them for real."  These synthetic cannabinoids have been associated with impaired driving incidents, attempted suicides, and emergency department visits, and have been linked to such adverse effects as increased anxiety, panic attacks, heart palpitations, respiratory complications, aggression, mood swings, altered perception, and paranoia.
  •  In 2010 there were 2,906 calls about synthetic marijuana products according to the American Association of Poison Control Centers’ (AAPCC) National Poison Data System (NPDS).  The poison centers reported 5,230 calls in 2012 (6,968 for all of 2011). The 2011 has doubled 2010 in the number of reported cases to the AAPCC. This national ban, unlike the synthetic cathinones ban, does not appear to be having a substantial effect on usage as 2012 is on track to equal or come close to 2011.  2013 saw 2,657 calls.
  •  2,906 in 2010  6,968 in 2011  5,230 in 2012  2,657 in 2013  For 2014 there have been 795 calls between January 1 – April 30 ◦ January 2013 179 calls. ◦ February 2013 165 calls. ◦ March 2013 205 calls. ◦ April 2013 246 calls.
  •  On November 24, 2010, the Federal Government took action to ban JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol (CP 47,497 C8, which is a homologue of CP 47,497).  The emergency ban was proposed to be in place for one year (March 2011 – March 2012, which has been extended for 6 more months) as federal officials study whether these 5 synthetic cannabinoid substances should be permanently controlled, however there are over 250 synthetic cannabinoids!  The Federal Government recently started an initiative to solve this problem as shown in the Poison Control Center Data, that there are so many synthetic cannabinoids, a ban on a small % will do nothing to deter use.  The Senate on May 24, 2012 passed the “ Food and Drug Administration Safety and Innovation Act” which has in it, a synthetic drug section (Title XI, Subtitle D – Section 1152). They expect this bill to be signed into law by the president on or before July 4, 2012.
  •  SEC. 1152. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT.  (a) Cannabimimetic Agents- Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end the following:  ‘(d)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.  (2) In paragraph (1):  ‘(A) The term ‘cannabimimetic agents’ means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays.  Thus the Federal Government is banning anything that binds to cannabinoid receptors (CB1 receptor as any drug that binds to CB2 does not produce a “high”)
  •  SEC. 1152. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT. (Which also specifically lists 18 chemicals)  ‘(i) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);  ‘(ii) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);  ‘(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);  ‘(iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);  ‘(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);  ‘(vi) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);  ‘(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);  ‘(viii) 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);  ‘(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);  ‘(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);  ‘(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);  ‘(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);  ‘(xiii) 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);  ‘(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8); and  ‘(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).’
  •  Bill A2644 has been introduced by New Jersey Assemblywoman Mary Pat Angelini proposing to ban JWH-018, JWH-073 & HU-210 in May, 2010. On January 11, 2011, The NJ Senate Introduced an identical bill, S2606. This bill was referred to the Senate Law and Public Safety Committee where both sat until February 28, 2012.  This Senate bill also only proposes to ban the same three (3) compounds the assembly bill proposes to ban, despite being introduced months after the proposed (and now enforced) emergency national ban (which has 5 substances listed).  Realizing these bills were written poorly, they were reconstructed and on February 28, 2012, a New Jersey bill banning the entire class of substances was put into place. Click here for the notice to law enforcement officials, and click here for the actual legislation verbiage. The legislation was signed on February 28th , 2012 and distributed on the 29th . This legislation seeks to imitate Washington State, North Carolina and Colorado in banning the entire class of the drug, not just individual chemicals (though individual chemicals are listed in the law).
  •  While the temporary national ban of five synthetic cannabinoids will not be the end of this story. Already on the internet there are the K2 and Spice portals of sale, stating that "there is a new generation of K2 products that are completely legal everywhere.”  Not covered by any ban, restriction or regulation! These are: K2 Sky, K2 Solid Sex, K2 Orisha, K2 Amazonian Shelter and K2 Thai Dream. As stated earlier, at least one K2/Spice distributor even went through the trouble of having their product tested which reported none of the nationally banned substances were in their product. Recently the Department of Homeland Security has a different view about  The Federal Government (then followed by each State Government) banning this entire class of substances (any cannabinoid that binds to CB1), including their salts, isomers, derivatives, analogues and homologues could see a dramatic reduction in the use of synthetic cannabinoids.  The question remains can such a broad brush uphold it’s intent in the US Courts, and that remains to be seen.
  • Glenn Duncan LPC, LCADC, CCS, ACS Presentation Last Updated 12-May-14
  • MDMA
  • Molly – Crystal Form
  • Molly Crystal-Powder Form
  • Molly – End User Sell Form
  •  MDMA was first synthesized in 1912 by Merck chemist Anton Köllisch.  At the time, Merck was interested in developing substances that stopped abnormal bleeding.  At the behest of his superiors Walther Beckh and Otto Wolfes, Köllisch developed a preparation of a hydrastinine analogue, methylhydrastinine. MDMA was an intermediate compound in the synthesis of methylhydrastinine, and Merck was not interested in its properties at the time.  On 24 December 1912, Merck filed two patent applications that described the synthesis of MDMAand its subsequent conversion to methylhydrastinine.
  •  In 1953 and 1954, the United States Army commissioned a study of toxicity and behavioral effects in animals of injected mescaline and several analogues, including MDMA.  The Army experimented with MDMA as an interrogation tool in Project MKUltra.  MDMA was being used recreationally in the United States by 1970.  In the early 1980s in the U.S., MDMA rose to prominence as "Adam" in trendy nightclubs and gay dance clubs in the Dallas area.  "Ecstasy" was recognized as slang for MDMA as early as June 1982. The drug was first proposed for scheduling by the Drug Enforcement Administration (DEA) in July 1984 and was classified as a Schedule I controlled substance in the U.S. May 31, 1985.
  •  MDMA (3,4-methylenedioxy-N-methylamphetamine) is an empathogenic drug of the phenethylamine and amphetamine classes of drugs.  Phenethylamine is found in many organisms and foods, such as chocolate. It is sold as a dietary supplement for purported mood and weight loss benefits.  Phenethylamine is the name of a class of chemicals with many members well known for psychoactive drug and stimulant effects.  MDMA has become widely known as "ecstasy" (shortened to "E", "X", or "XTC"), usually referring to its street pill form, although this term may also include the presence of possible adulterants.  The terms "mandy" or "molly" colloquially refer to MDMA in powder or crystalline form, usually implying a higher level of purity.
  •  MDMA can induce euphoria, a sense of intimacy with others, diminished anxiety, and mild psychedelia.  Many studies, particularly in the fields of psychology and cognitive therapy, have suggested MDMA has therapeutic benefits and facilitates therapy sessions in certain individuals, a practice for which it had been formally used in the past.  In the early 1980’s, MDMA was used by certain professionals conducting marriage therapy, because of its benefits to producing an enhanced sense of intimacy. After being made illegal in 1985, some therapists still recreationally prescribed the now illegal drug for therapy purposes.  Clinical trials are now testing the therapeutic potential of MDMA for post-traumatic stress disorder, anxiety associated with terminal cancer, and addiction.
  •  MDMA causes a reduction in the reuptake concentration of serotonin transporters in the brain.  The rate at which the brain recovers from serotonergic changes is unclear.  Some studies show MDMA may be neurotoxic in humans. One study demonstrated lasting serotonergic changes in some animals exposed to MDMA.  Other studies have suggested that the brain may recover from serotonergic damage. These studies suggest that any potential brain damage may be at least partially reversible following prolonged abstinence from MDMA.  Depression and deficits in memory have been shown to occur more frequently in long- term MDMA users.  However, some recent studies have suggested MDMA use may not be associated with chronic depression.
  •  Short-term physical health risks of MDMA consumption include hyperthermia, and hyponatremia.  Hyperthermia is the body’s inability to disperse body heat faster than it builds it, thus causing a potentially dangerous rise in body temperature.  Hyponatraemia is an electrolyte disturbance in which the sodium ion concentration in the plasma is lower than normal. Many conditions including congestive heart failure, liver failure, kidney failure and pneumonia can have an associated hyponatremia.  Continuous activity without sufficient rest or rehydration may cause body temperature to rise to dangerous levels, and loss of fluid via excessive perspiration puts the body at further risk as the stimulatory and euphoric qualities of the drug may render the user oblivious to their energy expenditure for quite some time.
  •  The primary effects attributable to MDMA consumption are predictable and fairly consistent among users. In general, users begin reporting subjective effects within 30–60 minutes of consumption, hitting a peak at about 75–120 minutes, reaching a plateau that lasts about 3.5 hours.  This is followed by a comedown of a few hours. After the drug has run its course, many users report feeling fatigue.
  •  The following subjective effects of MDMA: 1. Derealization 2. Depersonalization 3. Altered perception of space and time 4. Positive basic mood 5. Mania-like experience 6. Anxious derealization 7. Thought disorder 8. Fears of loss of thought or body control 9. Visual hallucinations or pseudo-hallucinations 10. Synesthesia (union of the senses) 11. Changed meaning of percepts 12. Facilitated recollection or imagination
  •  The following measurements were significantly increased by self- report of ecstasy users: 1. Self-confidence 2. Heightened mood 3. Apprehension-anxiety 4. Thoughtfulness-contemplativeness 5. Extroversion 6. Dazed state 7. Sensitivity and emotional excitation
  •  Effects reported by some users once the acute effects of MDMA have worn off include:  Psychological ◦ Anxiety and paranoia ◦ Depression ◦ Irritability ◦ Fatigue ◦ Impaired attention, focus, and concentration, as well as drive and motivation (due to depleted serotonin levels) ◦ Residual feelings of empathy, emotional sensitivity, and a sense of closeness to others (afterglow)  Physiological ◦ Dizziness, lightheadedness, or vertigo ◦ Loss of appetite ◦ Gastrointestinal disturbances, such as diarrhea or constipation ◦ Insomnia ◦ Aches and pains, usually from excessive physical activity (e.g., dancing) ◦ Exhaustion ◦ Jaw soreness, from bruxism
  • Glenn Duncan LPC, LCADC, CCS, ACS Presentation Last Updated 12-May-14
  • Prescription Opiates
  •  Prescription Opiates – Prescriptions for Opiates is the number one prescription in the United States, with cholesterol lowering drugs being 2nd .  Accidental drug overdoses is the 2nd leading cause of accidental deaths, only overshadowed by car accidents.  Prescriptions for opiates have increased by 1000% since the late 1990s.  In the 1970’s Heroin had a purity level that hovered around 6%, and today, depending on the location, that purity level averages in NJ around 60%, with up to 74%. This has allowed for a significant increase in non intravenous drug use of heroin. Prescription opiates account for the other aspect of significantly increased Non-IV opiate drug use.  In NJ, for the very first time, people coming into treatment (statistics are from licensed treatment facilities around the state of NJ), opiates have surpassed alcohol as the primary drug reported upon admission to treatment.
  •  The data for 2010 (the latest data from the Federal Government) shows drug overdose deaths rose for the 11th straight year, and most of them were accidents involving addictive painkillers despite growing attention to risks from these medicines.  In 2010, the CDC reported, there were 38,329 drug overdose deaths nationwide. Medicines, mostly prescription drugs, were involved in nearly 60 percent of overdose deaths that year, overshadowing deaths from illicit narcotics. Medication-related deaths accounted for 22,134 of the drug overdose deaths in 2010.  It details which drugs were at play in most of the fatalities. As in previous recent years, opioid drugs – which include OxyContin and Vicodin – were the biggest problem, contributing to 3 out of 4 medication overdose deaths.  Anti-anxiety drugs including Valium were among common causes of medication- related deaths, involved in almost 30 percent of them. Among the medication- related deaths, 17 percent were suicides.
  •  The legal amount of Vicodin or Percoset that can be prescribed is the following: 120 pills per month or a monthly dosage. Dosages of Percoset and Vicodin are in 5/325; 7.5/325; and 10/325 (Oxycodone or Hydrocodone/Acetometaphin).  Recently a doctor was found prescribing 100 10mg Percoset every 12 days for somebody’s pain, or 300 pills every 36 days (or 250 pills per 30 day month).  When asked, why so much, they stated the person’s pain warranted this, as they had developed a physical tolerance to the medication.  When asked why not switch to a more potent version of the drug (Oxycontin, which starts at 10mg tablets) that does not need 300 pills dispensed per month, the reply was the client is on Medicaid, and Medicaid only pays for Vicodin/Percoset.  In NJ, for the very first time, people coming into treatment (statistics are from licensed treatment facilities around the state of NJ), opiates have surpassed alcohol as the primary drug reported upon admission to treatment.
  •  Starting in the 2010-2011 cycle in NJ, opiates have surpassed alcohol as the primary drug reported upon admission to treatment.  Admissions: 7/1/2010 – 06/30/2011 Primary Drug Heroin & Other Opiates 28,983 40% (Intravenous Drug Users) 16,301 56% (Non-IV Drug Users) 12,682 44% Alcohol 23,473 34% Marijuana 11,219 16% Cocaine 4,769 07% Other Drugs 2,193 03%
  •  Admissions: 7/1/2011 – 06/30/2012 Primary Drug Heroin & Other Opiates 31,107 42% (Intravenous Drug Users) 17,733 57% (Non-IV Drug Users) 13,374 43% Alcohol 23,653 32% Marijuana 12,061 16% Cocaine 4,663 06% Other Drugs 2,480 04%
  •  Admissions: 7/1/2012 – 06/30/2013 Primary Drug Heroin & Other Opiates 34,197 45% (Intravenous Drug Users) 19,593 57% (Non-IV Drug Users) 14,604 43% Alcohol 23,210 31% Marijuana 12,243 16% Cocaine 4,084 05% Other Drugs 2,061 03%
  •  2012-2013 Heroin & Other Opiates 34,197 45%  2011-2012 Heroin & Other Opiates 31,107 42%  2010-2011 Heroin & Other Opiates 28,983 40% 2012-3 (IV Drug Users) 19,593 57% 2011-2 (IV Drug Users) 17,733 57% 2010-1 (IV Drug Users) 16,301 56% (Net Gain 3,292) 2012-3 (Non-IV Drug) 14,604 43% 2011-2 (Non-IV Drug) 13,374 43% 2010-1 (Non-IV Drug) 12,682 44% (Net Gain 1,922)
  •  The ease of obtaining the substance and how its done by individual addicts (there are professional teams of people who doctor shop in states like Florida and then ship the supplies up through the northeast quadrant): 1. Step 1: Have DOCUMENTED bad knees/other parts of your body; age also helps (the older the better, it’s harder for a 20yo to prove sustained pain). 2. Step 2: Find out what is maximum legal amount prescribed as a 1 month dosage. In NJ and FL it is 120 pills or a months supply as deemed by the doctor. If a doctor deems you need 400 pills per month, they have the legal capacity to prescribe as much. 3. Step 3: Go to a doctor who’s gives out medication like a PEZ dispenser 4. Step 4: Shop around, they don’t doctor shop per say (though many do), as that is illegal. However, what a good addict will do is to do their research, either first hand by going to different pain management practices, or researching on the internet. The object is to find the doctor who is willing to give you the most pills per month, and the highest dosage of those pills per month. E.g., there is a local doctor in the greater Hunterdon County area who is the “go to guy”, come in with the right MRI, X-Ray, etc., and correct income level [either low or high] and you could end up with 300 pills every 36 days.
  • Cough Syrup
  •  Purple drank is a slang term for a recreational drug popular, originating in Houston, Texas.  Its main ingredient is prescription-strength cough syrup containing codeine and promethazine.  Cough syrup is typically mixed with ingredients such as Sprite.  The purplish hue of purple drank comes from dyes in the cough syrup, or by adding a colored jolly rancher to the mixture.  There are numerous slang terms for purple drank, including sizzurp, lean, syrup, drank, barre, purple jelly, Texas tea, and Tsikuni.  There has been some reports of adding alcohol to the mix, but most “how to” pages on the internet state specifically to avoid this unless you are looking to potentially overdose.
  •  There can't at this time be said that there is a definitive link between smoking or snorting levamisole-adulterated cocaine, however recent literature (e.g., 2011 article from the Journal of the American Academy of Dermatology [JAAD]), and anecdotal reports suggest that this link does exist.  No one really understands why someone would add levamisole to cocaine, since it seems on the face of it to be bad business. However, levamisole has been shown to increase dopamine in the brain's reward pathway/circuit and so may actually enhance the effect of cocaine.  The authors (from the JAAD article) note that a 2009 paper published in the Annals of Pharmacotherapy suggested that cocaine itself may produce the pathology that seems to be associated with levamisole.  While there have been anecdotal reports that the 70% number reported in 2009 by SAMHSA is lower today, there is nothing definitive in the literature stating the amount of cocaine laced with levamisole is either higher or lower than what was reported in 2009.
  • Alcopops
  •  Alcopops are sweetened alcoholic beverages that are bubbly and fruit flavored. They are made to taste like soda, lemonade, punch and have 4-8% alcohol by volume.  They comprise over 100 brands, with the popular ones being Smirnoff Ice, Jack Daniel’s Original Hard Cola, Captain Morgan Gold, and Mike’s Hard Lemonade.  They are marketed to bring in new drinkers who don’t like the taste of beer and who haven’t matured to bourbon, vodka or other hard liquors.  While outlawed, they have come back with less caffeine. This is usually something that can be worked around by adding some redbull, or making your own Vodka and Redbull mixture.
  •  These drinks are marketed at the young population.  Alcohol marketers state they are aiming at the 21-30 year old crowd when marketing these drinks. However marketing research has shown that the 12-20 year old population drink twice the amount of alcopops that the 21-30 year old market does.  In 2005, NJ estimates were that 17.3% of total sales/consumption of alcopops were consumed by underage drinkers.  Alcohol Energy drinks are marketed at the same population, promoting “energy” while getting one drunk. The main ingredients are alcohol and caffeine. However, they are marketed with purportedly “healthy” ingredients such as Ginseng.
  •  Those who drink caffeinated alcoholic beverages are twice as likely as other drinkers to binge drink and act out with dangerous behavior, according to a recent study by Loma Linda researchers.  Drinks that have risen in popularity, such as Four Loko, lead to binge drinking and pose greater health risks when alcohol and caffeine are put together in large doses.  The university commissioned a survey of 1.4 million Californians that showed 25 percent of men and 10 percent of women admitted to binge drinking. When caffeinated alcohol drinks are added, users are twice as likely to binge drink, drive drunk, be injured or be sexually taken advantage of.  Binge drinking is defined as 5 drinks at one setting for males and 4 drinks for females.
  •  Alcohol ranks "most harmful" among a list of 20 drugs, beating out crack and heroin when assessed for its potential harm to the individual imbibing and harm to others, according to study results released by a British medical journal.  Overall, alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (54) in second and third places.  Scissors is a new mixture of codeine (sometimes substituted with Nyquil or DXM over the counter cough medicine), promethazine, Vodka, and Sprite.  Sometimes put a Jolly Rancher in it for color. There are probably 20+ rap songs that reference it in the past few years.
  •  When alcohol is inhaled it goes directly to the lungs, bypassing the stomach, small intestines and liver. This bypass causes none of the alcohol to be broken down.  Nebulized alcohol (oxygen with alcohol mist droplets) enters the bloodstream faster and its effects are more immediate than its liquid counterparts.  This will result in an enhanced euphoric effect, similar to drinking liquid alcohol on an empty stomach. (For similar rapid absorption, stimulants are insufflated instead of ingested. The rate of change is sensed by the nervous system.)  How to?: Pour liquor over dried and inhale the smoke. Heat alcohol over moderate temperatures and inhale the steam. Pressurize alcohol in a glass container and inhale the vapors. 
  •  Smoking alcohol is popular among people who want to lose weight and don’t want the calories that come from consuming alcohol.  “People think it is a great way to get the effects of alcohol without gaining the weight because alcohol has an enormous amount of empty calories.  You can’t be ingesting a lot of alcohol if you’re on a diet and want to lose weight,” says Dr. Deni Carise, the deputy chief clinical officer at CRC Health Group, a treatment- and educational-program provider for individuals struggling with behavioral issues, chemical dependency and eating disorders.  “I think adolescents are also particularly susceptible to this because it is novel and exciting.”
  •  http://www.awolspirit.com/  Or you could purchase this very expensive UK nebulizer, which recently was exclusively licensed in the US by a company in North Carolina called Spirit Partners.  However, North Carolina became another state which alcohol nebulizers, which has a potential national impact because they outlawed the distribution of nebulizers.  http://www.christiannewswire.com/news/630893469.html
  •  Reconstituted: Alcohol powder can be added to water to make an alcoholic beverage.  Oral: Alcohol powder is useful with capsules to eliminate the burning taste of certain alcohol upon ingestion.  Nebulizer: Alcohol powder produced through molecular encapsulated with cyclodextrin can be used with a nebulizer.  In 2008, Pulver Spirits was developing a line of alcohol powder products. The marketing was reportedly intended to be in full compliance with alcohol regulations and targeted at adults of legal drinking age.  In spring 2014 the Arizona-based company Lipsmark LLC announced that it would be marketing powdered alcohol from that fall under the name Palcohol. The product was briefly approved for sale by the ATF on April 8, 2014, but was later rescinded on April 21, 2014. 
  •  Vodka soaked gummy bears. Yes soaking gummy anything in vodka is the latest emerging trend. – Alcohol consumption media stoked fact:  Drug and alcohol counselors worry liquor-soaked gummy candy could make it more appealing for teenagers to take their first taste of alcohol.  Vodka-soaked tampons and butt chugging – Alcohol consumption media stoked myth turned into fact:  It gets absorbed directly into the bloodstream. There's no barrier, there's no stomach acid to prevent it. Boys will also reportedly use it and they'll insert it into their rectums.  Alcohol Enema – College fraternity stoked fact. Only a small amount is needed as the intestine absorbs the alcohol more quickly than the stomach.
  • Glenn Duncan LPC, LCADC, CCS, ACS Presentation Last Updated 12-May-14
  •  The most popular of the NBOMes are 25I-NBOMe (25I) and 25C-NBOMe (25C), and 25B-NBOMe (25B).  They are all N-Benzyl-Oxy-Methyl derivatives (thus "NBOMe") of previously known phenethylamines such as 2C-I and 2C-B.  An extra ring structure attached to the parent chemical results in a 10-20x increase in potency as well as changes to the experiential effects.
  •  Discovered in 2003 by Ralf Heim.  The chemicals first appeared on recreational markets in 2010.  By December 2012, the NBOMe compounds had drawn enough law enforcement interest for the DEA to publish a detailed analytical characterization.  The NBOMes are starting to be legally controlled.  The first ban was in Russia in October 2011, and the second was in the state of Virginia in April 2012.  In the first half of 2013, Arkansas, Florida, Louisiana, Israel, and the United Kingdom have all passed some type of criminal control.
  •  Doses of 750-1,000 ug (0.75-1 mg) of 25I or 25C, can cause a strong psychedelic experience with effects loosely comparable to those of LSD or 2C phenethylamines.  Many people report enjoying the effects, with some even saying they prefer 25I to LSD.  Most descriptions indicate that the NBOMes trigger less complex introspection than LSD, but produce strong visual and sensory effects, with the phrase "eye candy" occasionally being used.  As with most psychedelics, some people describe nausea as the effects begin.
  •  One of the most worrisome reported effects is vasoconstriction, including increased blood pressure, peripheral swelling, and cramping.  Vasoconstriction is also associated with high doses of other drugs, such as LSD, bromo-dragonfly, amphetamines, and MDMA.  The duration of 25I is a little shorter than LSD at comparable effect levels.  If LSD's normal full duration is considered 10-12 hours, 25I's is around 8-10 hours.  A number of users report less lingering stimulation after the primary effects have ended than with LSD.
  •  A great deal of 25I and 25C are sold to end-users as pure powder, which creates a hazardous situation.  Most people (especially 16- to 25-year-old experimenters) don't know the safety procedures necessary for handling super-potent compounds. Weighing and handling pure high-potency chemicals such as LSD or 25I-NBOMe should be performed wearing eye protection, gloves, and a filter mask. Yet such precautions are rarely followed.  Perhaps the greatest risk of the wide availability of pure NBOMe powders is confusing one white powder for another, or simply misunderstanding the difference between one psychedelic or stimulant drug and another.  Many people have prior experience with insufflating small lines or bumps of a psychedelic or stimulant. It's a fairly new phenomenon that a similarly-sized line of a drug could lead to death.  More than one of the documented 25I- or 25C-related deaths have followed insufflation of ten or more times the appropriate dosage.
  •  Bromo-DragonFLY is a psychedelic hallucinogenic drug related to the phenethylamine family. Bromo-DragonFLY is considered an extremely potent hallucinogen, only slightly less potent than LSD with a normal dose in the region of 200 μg to 800 μg, and it has an extremely long duration of action up to several days.  Although not illegal in the US, although it may be considered a controlled substance analogue under US drug laws, if used for consumption.  A Swedish man had to have the front part of his feet and several fingers on one hand amputated after taking a massive overdose.  Apparently the compound acted as a long-acting efficacious vasoconstrictor, leading to necrosis and gangrene which was delayed by several weeks after the overdose occurred.  Several other cases have also been reported of severe peripheral vasoconstriction following overdose with Bromo-DragonFLY.
  •  One case in 2008 in England involved inhalation of vomit, causing nearly fatal asphyxia.  Seizures have also been reported as potential effects of the drug.  The typical dose of Bromo-DragonFLY is not known, however it has varied from 500 μg to 1 mg. It has about 300 times the potency of mescaline, or 1/5 the potency of LSD. It has been sold in the form of blotters, similar to the distribution method of LSD.  It has a much longer duration of action than LSD and can last for up to 2–3 days. following a single large dose, with a slow onset of action that can take up to 6 hours before the effects are felt.
  •  2C-E is a psychedelic and phenethylamine (some of which are psychoactive drugs, including stimulants, psychedelics, opioids, and entactogens), of the 2C family.  The 2C's have been compared to a combination of a tryptamine with MDMA due to their tendency to cause visual hallucinations in tandem with warm rushes of euphoria, but this is only a very rough comparison. They have been classified as empathogens and entactogens to some degree. The initial come up can be somewhat lucid, "loopy", with alternating feelings of chills and warmth.  There can be a sense of pressure or swelling in the torso and head. The hands and body can shake or tremble, there can occur a tightness in the jaw. The body buzz tends to resolve during the latter half of the trip, and the psychological effects can be more pronounced.  They are a dose dependent drug (meaning different doses cause different effects).
  •  SEC. 1152. ADDITION OF SYNTHETIC DRUGS TO SCHEDULE I OF THE CONTROLLED SUBSTANCES ACT. (Adding an additional 11 drugs to Schedule 1)  (b) Other Drugs- Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended in subsection (c) by adding at the end the following:  ‘(18) 4-methylmethcathinone (Mephedrone).  ‘(19) 3,4-methylenedioxypyrovalerone (MDPV).  ‘(20) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).  ‘(21) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).  ‘(22) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).  ‘(23) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).  ‘(24) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).  ‘(25) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).  ‘(26) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).  ‘(27) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).  ‘(28) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).’.
  •  Phencyclidine (PCP) was developed in the 1950s as an intravenous anesthetic but, due to the side effects of hallucinations, delirium, and mania, its development for human medical use was discontinued in the 1960s by Parke Davis.  Ketamine, an anesthetic used in pediatric and veterinary medicine, was then developed and is structurally similar to PCP.  PCP is listed as a Schedule II drug by the US Drug Enforcement Agency. Ketamine is a Schedule III agent.  In its pure form, PCP is a white crystalline powder that readily dissolves in water or alcohol and has a distinctive bitter chemical taste.
  •  On the illicit drug market, PCP contains a number of contaminants causing the color to range from a light to darker brown with a powdery to a gummy mass consistency.  It is available in a variety of tablets, capsules, and colored powders, which are either taken orally or by insufflation ("snorted").  The liquid form of PCP is actually PCP base dissolved most often in ether, a highly flammable solvent.  For smoking, PCP is typically sprayed onto leafy material such as mint, parsley, oregano, or marijuana.  PCP may also be injected.
  •  A moderate amount of PCP often causes users to feel detached, distant, and estranged from their surroundings.  Numbness of the extremities, slurred speech, and loss of coordination may be accompanied by a sense of strength and invulnerability.  A blank stare, rapid and involuntary eye movements, and an exaggerated gait are among the more observable effects. Auditory hallucinations, image distortion, severe mood disorders, and amnesia may also occur.  In some users, PCP may cause acute anxiety and a feeling of impending doom; in others, paranoia and violent hostility, and in some, it may produce a psychoses indistinguishable from schizophrenia. Many believe PCP to be one of the most dangerous drugs of abuse.
  •  At high doses of PCP, there is a drop in blood pressure, pulse rate, and respiration.  This may be accompanied by nausea, vomiting, blurred vision, flicking up and down of the eyes, drooling, loss of balance, and dizziness.  High doses of PCP can also cause seizures, coma, and death (though death more often results from accidental injury or suicide during PCP intoxication).  Psychological effects at high doses include illusions and hallucinations.  Physiological effects of PCP include a slight increase in breathing rate and a more pronounced rise in blood pressure and pulse rate. Respiration becomes shallow, and flushing and profuse sweating.
  •  Ketamine is a dissociative anesthetic that has gained popularity as a drug of abuse.  On the street, it is commonly known as "K" or "Special K."  Other street names include Cat Valium, Super Acid, Special La Coke, Purple, Jet (slang in Texas), and Vitamin K.  Ketamine distorts perceptions of sight and sound and makes the user feel disconnected and not in control.  A "Special K" trip is touted as better than that of LSD or PCP because its hallucinatory effects are relatively short in duration, lasting approximately 30 to 60 minutes as opposed to several hours.
  •  Ketamine powder is usually snorted , mixed in drinks or smoked. Liquid ketamine is injected, applied on a smoke able material or consumed in drinks. Most abusers of ketamine take small lines or "bumps" for a mild, dreamy effect.  A dose of 100 mg is usually enough to enter a "k-hole" experience. A dose is referred to as a "bump.“  Ketamine is abused by many teenagers and young adults. The 2008 Monitoring the Future Report states the annual prevalence of ketamine among 8th , 10th , and 12th graders is 1.2%, 1.0%, and 1.5%, respectively.  According to IMS Health, the number of prescriptions of ketamine increased from 12,000 in 2006 to 16,000 in 2007 and remained at 16,000 in 2008.
  •  Kratom is a medicinal leaf harvested from large trees, commonly known as kratom trees.  The kratom tree grows best in wet, humid, fertile soil, with medium to full sun exposure, and an area protected from strong winds (usually grown and used in places such as Malaysia, Thailand, and Indonesia).  Kratom's primary pharmacology is mediated by the alkaloids 7-hydroxymitragynine and mitragynine.  Alkaloids are a group of naturally occurring chemical compounds and are produced by a large variety of organisms, including bacteria, fungi, plants, and animals.  Examples of famous alkaloids are the local anesthetic and stimulant cocaine; the stimulant caffeine; nicotine; the analgesic morphine (an alkaloid first extracted from the poppy plant in 1804 by Friedrich Sertürner, first distributed by Friedrich in 1817, and first commercially sold by Merck in 1827).
  •  The common belief is Kratom acts as a stimulant in lower doses, becoming sedative in higher doses.  The alkaloid mitragynine is attributed to act as a stimulant. Though some research has shown that mitragynine, the major alkaloid identified from Kratom, has been reported as a partial opioid agonist producing similar effects to morphine.  The alkaloid 7-hydroxymitragynine (still believed to be a minor alkaloid involved in Kratom, though more recent research shows it to be the major contributor to the opioid type high) is the most significant alkaloid for sedation with more potent analgesic activity than that of morphine.  Effects come on within five to ten minutes after use, and last for several hours. The feeling has been described as happy, strong, and active, with a strong desire to do work. The mind is described as calm.  Kratom itself is believed to be similarly addictive if abused.
  •  Ceiling effect: limits respiratory depression and euphoria.  No fatal overdose of kratom known to have occurred, at least in reported literature.  Short-term (immediate) ◦ Dry mouth ◦ Increased or decreased urination ◦ loss of appetite ◦ Nausea and/or vomiting.  Side effects (Intermediate) ◦ Anorexia/weight loss ◦ Insomnia ◦ Dependence (addiction). This is postulated, there is no research on the addictive components of Kratom. Some argue that only large, repeated daily use has the potential for addiction, and recreational use does not.
  •  Daily kratom users can develop a dependency similar to that of opiate addiction; however, withdrawals from kratom are said to be substantially less severe and shorter in duration. If used sporadically, kratom dependency is believed to be remote.  Kratom is a controlled substance in Thailand, Bhutan, Australia, Finland, Denmark, Poland, Lithuania and Sweden as of September, 1, 2011.  Kratom is also illegal in Malaysia and Myanmar (Burma). In Malaysia, kratom is scheduled under the Poisons Act.  In Canada, although kratom has not been approved by Health Canada for human consumption, it currently does not fall under the purview of the Controlled Drugs and Substances Act thus, remaining largely unregulated.  Kratom is currently unregulated in the United States and hasn’t appeared on DEA’s radar.
  •  Plants in the Mint family  Sage  Common Sage  Mexican Bush Sage  White Sage  Greek Sage  Diviner's Sage (Salvia Divinorum)
  •  Salvia divinorum is an unscheduled dietary supplements whose active agents are opioid receptor agonists, and has discrete psychoactive effects that have contributed to their increasing popularity.  Salvia divinorum contains the highly selective kappa-opioid receptor agonist Salvinorin A.  Despite their widespread Internet availability, use of Salvia divinorum and Kratom represents an emerging trend that escapes traditional methods of toxicologic monitoring (i.e., they are not detectable on drug tests).  Salvia divinorum was first recorded in print by Jean Basset Johnson in 1939 while he was studying Mexican Mazatec shamanism. Salvia divinorum is a Mexican plant which has a long history of use by Mazatec shamans. It was not until the 1990s that the psychoactive mechanism was identified by a team led by Daniel Siebert.
  •  Salvinorin A is the main active psychotropic molecule in Salvia divinorum. Salvinorin A is a hallucinogenic compound with psychedelic/dissociative effects.  It is structurally distinct from other naturally occurring hallucinogens (such as DMT, psilocybin, and mescaline) because it contains no nitrogen atoms, hence it is not an alkaloid. It is the most potent natural hallucinogen.  The Internet has allowed for the growth of many businesses selling live salvia plants, dried leaves, extracts, and other preparations.  Medical experts, as well as accident and emergency rooms, have not been reporting cases that suggest particular salvia-related health concerns.  Police have not been reporting it as a significant issue with regard to public order offences; in any case, Salvia divinorum has attracted negative attention from the media and some lawmakers.
  •  The controversial suicide of teenager, Brett Chidester (from Delaware, who’s death led to Brett’s Law which is the Delaware Law prohibiting the use of Salvia Divinorum & Salvinorin A) is felt by some one cause of the negative media attention on Salvia Divinorum.  It is seen as controversial by some as the family of Chidester believed his use of Salvia Divinorum caused him to commit suicide by lighting a charcoal grill inside a tent.  There have been no other reports of suicidal ideation caused by Salvia Divinorum, nor do emergency room visits or poison control centers show data to support the kind of reactions that are see with synthetic cannabinoids (Spice/K2) and “Bath Salts”. The addiction potential is low.  Psychedelics amplify a person’s internal state of mind. If you’re already having some kind of dark thoughts, a psychedelic experience could amplify that, and it could lead to a problem for some people.
  •  According to the National Survey on Drug Use and Health Report (NSDUH) published by SAMHSA in February 2008, it is estimated that 1.8 million persons aged 12 or older used Salvia Divinorum in their lifetime, and approximately 750,000 did so in the past year.  Use was more common among young adults (18 to 25 years old) as opposed to older adults (>25 years of age).  Young adults were 3 times more likely than youths aged 12 to 17 to have used Salvia Divinorum in the past year.  Use is more common in males than females according to NSDUH.  Salvia Divinorum and Salvinorin A are not currently Federally controlled under the Controlled Substances Act.
  •  Smoked  Unnoticeable or light effects from dry leaf  More intense effects from higher doses ◦ Uncontrollable laughter ◦ Past memories, such as revisiting places from childhood memory ◦ Sensations of motion, or being pulled or twisted by forces ◦ Visions of membranes, films and various two-dimensional surfaces ◦ Merging with or becoming objects ◦ Overlapping realities, such as the perception of being in several locations at once.
  •  This drug is currently legal in NJ, and has an assembly bill proposing to outlaw Salvia Divinorum and Salvinorin A (Assembly Bill A1243, proposed on January 12, 2010 and sent to the Assembly Judiciary Committee … where it still sits).  In Pennsylvania (on June 23, 2011), SB 1006 was passed by the House, Senate and approved by the Governor. This bill SB 1006 bans 6 synthetic stimulants including MDPV and Mephedrone, and Salvia Divinorum and Savlinorin A.  This Pennsylvania Act became law on 08/22/11.  You can view SB 1006's history by clicking here. This law also banned a group of psychedelics known as the 2C group, with the most famous of these drugs being 2C-E. The additions to Pennsylvania’s law that SB 1006 included, make this law one of the most comprehensive in the nation.
  •  The following States have made this a “Schedule I” Illegal Substance as of 09/12/12: Alabama, Delaware, Florida, Hawaii, Illinois, Indiana, Kansas, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Nebraska, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, and Virginia.  Minnesota – “Gross Misdemeanor”. South Dakota – “Class 1 Misdemeanor/Class 6 Felony. Tennessee – Class A Misdemeanor.  Wisconsin – Not a “Schedule I” Illegal substance but “prohibits manufacturing, distributing, or delivering Salvinorin A with the intent that it be consumed by a person.”  Georgia – listed as a “dangerous drug”. This law allows for "possession, planting, cultivation, growing, or harvesting of Salvia divinorum strictly for aesthetic, landscaping, or decorative purposes."  California, Maine – only prohibited by making it illegal to sell to minors.
  •  Dextromethorphan is the d-isomer of levorphanol, an opioid related to codeine.  So what does “d-isomer” mean?: The designation meaning dextrorotatory, or an asymmetric molecule that has the ability to rotate polarized light in a clockwise direction.  There are approximately 140 prescription and nonprescription drug products that contain dextromethorphan in combination with other active ingredients such as acetaminophen, antihistamines, decongestants, topical anesthetics, guaifenesin, promethazine, and ethanol.  Typical amounts of dextromethorphan hydrobromide (HBr) in various products include: liquids, 3.3–15 mg/5 mL; tablets and capsules, 10–30 mg; extended-release tablets, 30–60 mg; lozenges, 2.5–7.5 mg; and powders, 20–30 mg.
  •  Dextromethorphan was approved by the US Food and Drug Administration in 1958 as a nonprescription drug to suppress cough and is now marketed throughout the world.  Dextromethorphan abuse started becoming popularized in the mid to late 1990’s and that popularity increased until approximately 2005. Its misuse/abuse has leveled off since that time, but it is still a popular drug for teens to abuse.  The Association of Poison Control Centers, the number of cases involving dextromethorphan abuse or misuse by teenagers reported to poison centers in the US tripled between 2000 and 2003.  During 1999–2004, US poison control centers managed 15,543 cases of dextromethorphan abuse as a single substance.
  •  The Drug Abuse Warning Network (DAWN ED) reports that an estimated 7,739 emergency department visits were associated with non-medical use of dextromethorphan in 2006, 10,410 visits in 2007 and 7,988 visits in 2008.  According to the American Association of Poison Control Centers, there were 52,991 case mentions and 40,229 single exposures related to DXM in 2008.  Abusers of DXM describe four dose-dependent “plateaux:” Plateau Dose (mg) Behavioral Effects 1st 100–200 Mild stimulation 2nd 200–400 Euphoria and hallucinations 3rd 300–600 Distorted visual perceptions Loss of motor coordination 4th 500-1500 Dissociative sedation
  •  DXM abusers report a heightened sense of perceptual awareness, altered time perception, and visual hallucinations.  The typical clinical presentation of DXM intoxication involves hyperexcitability, lethargy, ataxia (an inability to coordinate voluntary muscular movements), slurred speech, sweating, hypertension, and/or nystagmus (a rapid involuntary oscillation of the eyeballs).  Abuse of combination DXM products also results in health complications from the other active ingredient(s), which include increased blood pressure from pseudoephedrine, potential delayed liver damage from acetaminophen, and central nervous system toxicity, cardiovascular toxicity and anticholinergic (blocking the physiologic action of acetylcholine) toxicity from antihistamines.  The abuse of high doses of DXM in combination with alcohol or other drugs is particularly dangerous and deaths have been reported.
  •  Poisoning with dextromethorphan can follow the unintentional ingestion of a single large dose or it can follow chronic use of supratherapeutic (more than) doses. Dextromethorphan is also used as a substance of abuse or a means to attempt suicide.  Based on a report from the Drug Abuse Warning Network of US emergency departments, 12,584 people sought emergency treatment in 2004 for dextromethorphan-related problems, representing 0.7% of all drug-related visits.  The reasons for the dextromethorphan-related emergency department visits involved non-medical use (abuse) in 5,581 patients (44.3%), adverse effects from therapeutic use in 3,810 (30.3%), attempted suicide in 1,770 (14.1%), and unintentional ingestion in 1,423 (11.3%).  Patients aged 12–20 years accounted for nearly one-half (48%) of all the visits resulting from the abuse of dextromethorphan. For unintentional ingestions, 94% of patients were under 12 years of age.
  •  Krokodil has roughly the same effect as heroin but is at least three times cheaper and extremely easy to make.  The active component is codeine, a widely sold over-the-counter painkiller that is not toxic on its own.  But to produce krokodil, whose medical name is desomorphine, addicts mix it with ingredients including gasoline, paint thinner, hydrochloric acid, iodine and red phosphorous, which they scrape from the striking pads on matchboxes.  In 2010, between a few hundred thousand and a million people, according to various official estimates, were injecting the resulting substance into their veins in Russia, so far the only country in the world to see the drug grow into an epidemic.
  •  Derived from cocaine, oxi (short for oxidado or “rust”) may also contain kerosene or gasoline as well as acetone, battery acid or assorted other chemicals. The drug is smoked and has a nearly instantaneous effect.  The pleasure of this drug is at this very moment. When you inhale, it's the first five seconds that is the ecstasy of this drug, when it comes to your brain. You feel your ear making a buzzing sound. You forget everything.  The effects of oxi on users are devastating. Users take on a yellowish skin color, lose weight very quickly and develop liver problems. They start to look like emaciated living corpses in just a few weeks time. The drug causes stomach aches, vomiting and constant diarrhea, but perhaps the most alarming fact is that most users die within a year.  Use of oxi has exploded in Brazil since 2005. Oxi has already gripped most of Brazil's seven northern states that make up the Amazon region, and in recent months it has been seen in large population centers in the south of Brazil.
  • Use -Mild Use – Mod/Sev Intoxication Withdrawal Alcohol X X X X Cannabis X X X New to DSM- 5 Caffeine X New to DSM- 5 Amphetamines X X X X Cocaine X X X X Hallucinogens X X X Phencyclidine (PCP) X X X Tobacco New to DSM- 5 X X Opioids X X X X Inhalants X X X Sedatives, Hypnotics X X X X Polysubstanc e Out in DSM-5
  • Substance-Use Disorder  A.A problematic pattern of [substance] use leading to clinically significant impairment or distress. B.Two (or more) of the following occurring within a 12-month period: 1. [Substance] is often taken in larger amounts or over a longer period than was intended 2. There is a persistent desire or unsuccessful effort to cut down or control [substance] use 3. A great deal of time is spent in activities necessary to obtain [substance] , use the substance, or recover from its effects 4. Craving or a strong desire or urge to use [substance] 5. Recurrent [substance] use resulting in a failure to fulfill major role obligations at work, school, or home. 6. Continued [substance] use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance
  • Substance-Use Disorder (continued) B.Two (or more) of the following occurring within a 12-month period: 7. Important social, occupational, or recreational activities are given up or reduced because of [substance] use 8. Recurrent [substance] use in situations in which it is physically hazardous. 9. Continued [substance] use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance 10.Tolerance, as defined by either or both of the following: a. A need for markedly increased amounts of [substance] to achieve intoxication or desired effect b. Markedly diminished effect with continued use of the same amount of the substance (Note: This criterion is not considered to be met for those taking [substance] solely under appropriate medical supervision)
  • Substance-Use Disorder (continued) B.Two (or more) of the following occurring within a 12-month period: 11.Withdrawal, as manifested by either of the following: a. The characteristic [substance] withdrawal syndrome (refer to Criteria A and B of the criteria set for Withdrawal) b. [Substance] (or a closely related substance) is taken to relieve or avoid withdrawal symptoms (Note: This criterion is not considered to be met for those taking [substance] solely under appropriate medical supervision)
  • Substance-Use Disorder (continued) Specify if: In early remission: After full criteria for [substance] use disorder were previously met, none of the criteria for [substance] use disorder have been met for at least 3 months but for less than 12 months (with the exception that Criterion A4, (“Craving, or a strong desire to urge to use [substance],” may be met). In sustained remission: After full criteria for [substance] use disorder were previously met, none of the criteria for [substance] use disorder have been met at any time during a period of 12 months or longer (with the exception that Criterion A4, (“Craving, or a strong desire to urge to use [substance],” may be met).
  • Specify if: On maintenance therapy: This additional specifier is used if the individual is taking prescribed agonist medication such as methadone or buprenorphine and none of the criteria for opioid use disorder have been met for that class of medication (except for tolerance to, or withdrawal from, the agonist). This category also applies to those individuals being maintained on a partial agonist, an agonist/antagonist, or full antagonist such as oral naltrexone or depot naltrexone. In a controlled environment: This additional specifier is used if the individual in an environment where access to [substance] is restricted. NOTE: The “on maintenance therapy” specifier applies as a further specifier of remission if the individual is both in remission and receiving maintenance therapy (i.e., in early remission on maintenance therapy or in sustained remission on maintenance therapy).
  • Substance-Use Disorder (continued) The Severity of each Substance Use Disorder is based on: ◦ 0 criteria or 1 criterion: No diagnosis ◦ 2-3 criteria: Mild Substance Use Disorder ◦ 4-5 criteria: Moderate Substance Use Disorder ◦ 6 or more criteria: Severe Substance Use Disorder ◦ Among adolescents, 2 or 3 criteria identify a group with severity of alcohol use disorder very close to that of adolescents with DSM-IV alcohol abuse, while 4 or more criteria identify a group with severity very close to that of DSM-IV dependence. Using criterion counts results in much more homogeneous groups than DSM-IV’s abuse and dependence groups. ◦ In the empirical research among adults, the proposed cutoff points have been shown to yield similar prevalence and high concordance in relation to the combined DSM-IV substance abuse and dependence diagnoses. However, it is still unclear as to whether 4-5 or 6 or more constitute what used to be substance dependence in adults.
  • Substance-Use Disorder (Legal Problems – OUT; Cravings – IN) Craving is defined as a strong desire for a substance, usually a specific substance. It is a common clinical symptom, tending to be present on the severe end of the severity spectrum. It has been variously defined as a trait with a time component (present or recent past) or as a lifetime component (ever experienced in your life). Brain imaging studies have demonstrated subjective craving precipitated by drug- related cues and correlated with increased activity (blood flow) and dopamine release (PET study) in specific parts of the brain reward system. Recurrent substance-related legal problems (e.g., arrests for substance related disorderly conduct). DSM-5 aggregate research all indicate that the legal problems criterion has an extremely low prevalence relative to other criteria, and its removal from the diagnosis has very little effect on the prevalence of substance use disorders while adding little information to the diagnoses in the aggregate. 
  • Substance-Use Disorder (Cravings) "Craving." An innovation in the diagnosis of substance use disorders is a requirement that the patient report or demonstrate craving for the particular substance. Workgroup chairman Charles O'Brien, MD, of the University of Pennsylvania, said this is the key symptom that separates addiction from mere heavy use. He added that a wealth of recent research has established that craving can be measured -- he had hoped that an objective test might be included in the DSM-5 criteria, but his workgroup felt it was not ready quite yet.
  • Substance-Use and Addictive Disorders New Categories Alcohol Use Disorder Cannabis Use Disorder Hallucinogen Use Disorder (which has subsumed Phencyclidine [PCP]) Inhalant Use Disorder Opioid Use Disorder Sedative/Hypnotic/Anxiolytic Use Disorder Stimulant Use Disorder (combining DSM-IV-TR’s Cocaine and Amphetamine Abuse and Dependence) Tobacco Use Disorder Other/Unknown Substance Use Disorder Gambling Disorder
  •  American Daily Herald [online]. (2011). Oxi: New Dangerous Drug Spreads In Brazil. http://www.americandailyherald.com/20110520530/americas/oxi-new-dangerous-drug-spreads-in-brazil  Answers.com for the definition of d-isomer: http://www.answers.com/topic/d-isomer  Babu, K. M., McCurdy, C. R., & Boyer, E. W. (2008) Opioid receptors and legal highs: Salvia divinorum and Kratom. Clinical Toxicology, 46(2), 146-152.  Chung, C., Tumeh, P. C., Birnbaum, R., Tan, B. H., Sharp, L., McCoy, E., Mercurio, M. G., & Craft, N. (2011). Characteristic purpura of the ears, vasculitis, and neutropenia–a potential public health epidemic associated with levamisole-adulterated cocaine. Journal of the American Academy of Dermatology.  Drugs.com – Information on PCP. http://www.drugs.com/pcp.html  U.S. Government – (2012). Electronic Codes of Federal Regulations. PART 1308—SCHEDULES OF CONTROLLED SUBSTANCES http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&rgn=div5&view=text&node=21:9.0.1.1.9&idno=21#21:9.0.1.1.9.0.26.4  Kratom Illegal in Sweden as of September, 2011. http://www3.lrs.lt/pls/inter3/dokpaieska.showdoc_l?p_id=328773  NCADD of New Jersey. (2010). Fact Sheet on Alcopops.  NCADI – Straight Facts About Drugs and Alcohol. (2001). http://www.health.org/govpubs/rpo884/
  •  New Jersey Substance Abuse Monitoring System (NJSAMS). (2010 and 2011). Substance Abuse Treatment Admissions, State of NJ Totals. https://njsams.rutgers.edu/samsmain/mainhome.htm (accessed online 10/17/11 and 06/26/12)  Partnership for a Drug Free America. (Accessing information regarding prescription opiates) http://www.drugfree.org and http://www.drugfree.org/wp-content/uploads/2011/09/drug-guide-2.pdf?utm_source=drug%2Bguide%2Blanding%2Bpage&utm_medium=rx% (accessed online 10/17/11).  SAMHSA Press. (2009). Nationwide Public Health Alert Issued Concerning Life-Threatening Risk Posed by Cocaine Laced with Veterinary Anti-Parasite Drug. http://www.samhsa.gov/newsroom/advisories/090921vet5101.aspx  Time.com. (2011). The Curse of the Crocodile: Russia's Deadly Designer Drug. http://www.time.com/time/world/article/0,8599,2078355,00.html (accessed online 10/17/11).  Time.com (2013). Drug overdoses climb for the 11th consecutive year. http://healthland.time.com/2013/02/20/drug-overdoses-climb-for-11th-consecutive-year/ (accessed 02/20/13).  Wikipedia: Alkaloid. http://en.wikipedia.org/wiki/Alkaloid (accessed online 09/11/11).  Wikipedia: Kratom. http://en.wikipedia.org/wiki/Kratom (accessed online 09/11/11).  Wikipedia: Morphine. http://en.wikipedia.org/wiki/Morphine (accessed online 09/11/11).  Wikipedia: MDMA. http://en.wikipedia.org/wiki/MDMA (accessed online 11/17/13).
  •  Wikipedia: 2C-E. http://en.wikipedia.org/wiki/2C-E (accessed online 11/18/11).  Wikipedia: Phenethylamines. http://en.wikipedia.org/wiki/Phenethylamines (accessed online 11/18/11).  Wikipedia: Bromo-DragonFLY. http://en.wikipedia.org/wiki/Bromo-DragonFLY (accessed online 11/29/11).  Chart summarizing different research chemicals was accessed 11/29/11 at http://www.drugs-forum.com/forum/showwiki.php?title=Category:Research_Chemicals  NBOMe – The Vaults of Erowid. Spotlight on NBOMe. First published online in July, 2013. Accessed 05/12/14. http://www.erowid.org/chemicals/nbome/nbome_article1.shtml  American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.  Wikipedia: Powdered Alcohol. http://en.wikipedia.org/wiki/Alcohol_powder (accessed online 05/12/14). Also see: http://www.palcohol.com
  •  American Association of Poison Control Centers. (2011). Bath Salts Data Updated April 30, 2014. https:// aapcc.s3.amazonaws.com/files/library/Bath_Salts_Web_Data_through_4.2014.pdf  American Psychiatric Association Online (2011). Why "Bath Salts" Are Addictive. http://alert.psychiatricnews.org/2011/12/why-bath-salts-are-addictive.html (accessed 12/28/11)  Bangor Daily News Online – Maine Politics. (2011). ‘Bath salts’ ban takes effect; state’s top cop seeks to halt drug’s march into Maine. http://bangordailynews.com/2011/07/06/politics/lepage-signs-bill-creating-penalties-for-bath-salts/  DEA. (2011). Chemicals Used in "Bath Salts” Now Under Federal Control and Regulation. (DEA Will Study Whether To Permanently Control Three Substances). http://www.justice.gov/dea/pubs/pressrel/pr102111.html  DEA. (2010). Brief Statement Regarding Emerging Drug MDPV. http://www.justice.gov/dea/index.htm  DEA. (2010). Increasing abuse of bath salts. http://www.justice.gov/ndic/pubs43/43474/sw0007.doc  DEA. (2010). Methylenedioxypyrovalerone [(MDPV) (1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone] http://www.deadiversion.usdoj.gov/drugs_concern/mdpv.pdf  DEA. (2010) 4-methylmethcathinone, Mephedrone, 4-MMC - Drugs and Chemicals of Concern. http://www.deadiversion.usdoj.gov/drugs_concern/mephedrone.htm
  •  Drugs Forum. Information regarding MDPV accessed on February 22, 2011. http://www.drugs-forum.com/forum/showwiki.php?title=MDPV  The Federal Government (2012). S. 3187: Food and Drug Administration Safety and Innovation Act – Synthetic Drugs http://www.govtrack.us/congress/bills/112/s3187/text  FoxNews.com. (2011). Delaware Officials Ban Sale of 'Bath Salts’ http://www.foxnews.com/politics/2011/09/30/delaware-officials-ban-sale-bath-salts/  Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE. (2011). 4-Methylmethcathinone (mephedrone): Neuropharmacological effects of a designer stimulant of abuse. Journal of Pharmacology and Experimental Therapeutics. 339(2):530–536.  Huffington Post. (2011). Rutgers Student William Parisio, Accused In Pamela Schmidt's Murder, Used 'Bath Salts' To Get High. http://www.huffingtonpost.com/2011/03/16/pamela-schmidt-dead_n_836536.html  Huffington Post. (2011). Bath Salts Drug Not Involved In Murder Leading To Pamela's Law Ban, NJ Prosecutor Says. http://www.huffingtonpost.com/2011/09/02/nj-murder-bath-salts-drug-ban-william-parisio-pamela-schmidt_n_947159.html  Kehr, J.; Ichinose, F.; Yoshitake, S.; Goiny, M.; Sievertsson, T.; Nyberg, F.; Yoshitake, T. (2011). "Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats". British Journal of Pharmacology 164 (8): 1949–1958.
  •  KMBC.com – Abuse of Fake ‘Bath Salts’ Sends Dozens to ER. http://www.kmbc.com/news/26256067/detail.html  National Institute on Drug Abuse. (2011). Message from the Director on "Bath Salts" - Emerging and Dangerous Products. http://www.nida.nih.gov/about/welcome/MessageBathSalts211.html  New Jersey Star Ledger. (2011). N.J. Senate, Assembly lawmakers to introduce bill banning 'bath salts' drug. http://www.nj.com/news/index.ssf/2011/03/nj_legislation_banning_bath_sa.html  Office of National Drug Control Policy. (2011). Statement from White House Drug Policy Director on Synthetic Stimulants, a.k.a “Bath Salts”. http://www.whitehousedrugpolicy.gov/news/press11/020111.html  The Poison Review. (2011). NBC’s Today Show reports on ‘bath salts’. http://www.thepoisonreview.com/2011/02/02/the-today-show-reports-on-bath-salts-mdpv/  Psychonaut Webmapping Research Group. (2009). MDPV Report. Institute of Psychiatry, King’s College London: London, UK. http://www.nascsa.org/NEWS/PsychonautMDPVreport.pdf  NJ's Pamela's Law. (2010). http://e-lobbyist.com/gaits/text/288194 - NJ Law banning 6 Synthetic Cathinones (MDPV, Mephedrone, Methylone, Methedrone, Flephedrone, and 3-FMC).  Redwood Toxicology Laboratories. (2011). http://www.redwoodtoxicology.com/documents/services/3396_designer_stimulant_sellsheet.pdf
  •  SeattleWeekly.com. (2011). Washington Permanently Bans Bath Salts and Synthetic Marijuana--and Some Chemicals That Haven't Been Invented Yet. http://blogs.seattleweekly.com/dailyweekly/2011/10/washington_permanently_bans_bath_salts_and_synthetic_marijuana .php  Synthetic Cathinones. (2011). European Monitoring Centre for Drugs and Drug Addiction. http://www.emcdda.europa.eu/publications/drug-profiles/synthetic-cathinones  Westfield Patch. (2011). http://westfield.patch.com/articles/christie-bans-bath-salts Christie Bans "Bath Salts“  Wikipedia: 3,4 DMMC. http://en.wikipedia.org/wiki/3,4-Dimethylmethcathinone  Wikipedia: alpha-PVP. http://en.wikipedia.org/wiki/%CE%91-PVP  Wikipedia: alpha-Pyrrolidinopropiophenone. http://en.wikipedia.org/wiki/Alpha-pyrrolidinopropiophenone  Wikipedia: Mephedrone. http://en.wikipedia.org/wiki/Mephedrone  Wikipedia: MPPP. http://en.wikipedia.org/wiki/4%27-Methyl-%CE%B1-pyrrolidinopropiophenone  Wikipedia: MDPPP. http://en.wikipedia.org/wiki/3%27,4%27-Methylenedioxy-%CE%B1-pyrrolidinopropiophenone
  •  Wikipedia: MDPV. http://en.wikipedia.org/wiki/MDPV  Wikipedia: Substituted Cathinones. http://en.wikipedia.org/wiki/Substituted_cathinone  WJHG.com – Florida makes sales and possession of bath salts illegal. http://www.wjhg.com/home/headlines/Florida_makes_sales_and_possession_of_bath_salts_illegal_114 681959.html  Wood, D. M., Greene, S. L. & Dargan, P. I. (2011). Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: mephedrone (4- methylmethcathinone) control appears to be effective using this model. Emergency Medical Journal. http://emj.bmj.com/content/early/2011/10/27/emermed-2011-200747.abstract  Information from the slide “Synthetic Cathinones Effects Summary Sheet” was taken from: Martha Hunt, M.A., CAMF, Health Promotion & Wellness, Naval Hospital Twentynine Palms, MCAGCC, Box 788250, Twentynine Palms, CA 92278. PowerPoint presentation entitled “Bath Salts or Designer Cathinones”, August 9, 2011. Accessed September, 14, 2011.
  •  The information on Spice/K2 was taken from: http://www.hdap.org/spice.html This article was last updated on 03/06/11 and uses citations from 20 sources dating from 2008 – 2011. The PowerPoint uses the following citations:  American Association of Poison Control Centers – Synthetic Marijuana Data Updated April 30, 2014. https://aapcc.s3.amazonaws.com/files/library/Syn_Marijuana_Web_Data_through_4.2014.pdf  Countyourculture.com: Synthetic Cannabinoids: JWH-018 Replacements. (2010). http://countyourculture.com/2010/12/06/synthetic-cannabinoids-jwh-018-replacements  DEA - Emergency Scheduling of K2/Spice-type Products: http://www.justice.gov/dea/pubs/abuse/k2.htm  Federal Register, 76 (40). (2011). Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I. http://bit.ly/fsrIUE  The Federal Government (2012). S. 3187: Food and Drug Administration Safety and Innovation Act – Synthetic Drugs http://www.govtrack.us/congress/bills/112/s3187/text
  •  New Jersey Synthetic Cannabinoid Bill A2644 Progress: http://e-lobbyist.com/gaits/NJ/A2644 and text of the bill: http://www.njleg.state.nj.us/2010/Bills/A3000/2644_I1.HTM  New Jersey Synthetic Cannabinoid Senate Bill S2606 Progress: http://e- lobbyist.com/gaits/view/221202 and text of the bill: http://www.legis.state.pa.us/CFDOCS/Legis/PN/Public/btCheck.cfm? txtType=HTM&sessYr=2009&sessInd=0&billBody=H&billTyp=B&billNbr=0176&pn=4329  New Jersey’s Synthetic Cannabinoid Law: Law enforcement announcement - http://www.hdap.org/spice-ban-NJ-law-enforcement-notice-022912.pdf. Legislation adopted on 02/28/12 - http://www.hdap.org/spice-ban-NJ-legislation-022912.pdf.  NYTimes.com: Synthetic Marijuana Spurs State Bans: http://www.nytimes.com/2010/07/11/us/11k2.html?_r=1  Pennsylvania's House Republican Caucus - Stern’s Fight to Get Bath Salts Listed as a Controlled Substance Moves One Step Closer to Becoming Law. http://www.pahousegop.com/NewsItem.aspx? NewsID=11643
  •  Redwood Toxicology - Composition Of Various Smokable Herbal Mixtures & Incense Blends (also a link to their testing website): http://www.redwoodtoxicology.com/documents/services/3381_jwh_composition.pdf http://www.redwoodtoxicology.com/services/synthetic_cannabinoid_testing.html  Wikipedia: Synthetic Cannabinoids: http://en.wikipedia.org/wiki/Synthetic_cannabis
  •  Glenn Duncan LPC, LCADC, CCS, ACS is the Executive Director of Hunterdon Drug Awareness Program, an outpatient and intensive outpatient substance abuse program located in Flemington, NJ. Glenn is also a national trainer and professional consultant, providing trainings on both emerging drug trends, clinical supervision and other topics.  If you had questions that did not get answered, Glenn can be contacted at info@clinicalsupervisor.net, gduncan@hdap.org, or you can contact him on linked in at: http://www.linkedin.com/in/glennduncan.